Publications

  1. Choung RS, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Associations between medication use and functional gastrointestinal disorders: a population-based study. Neurogastroenterol Motil. 2013 May; 25(5):413-9, e298. Epub 2013 Jan 29. 2299989
    View PubMed
  2. Topazian M, Camilleri M, Enders FT, Clain JE, Gleeson FC, Levy MJ, Rajan E, Nehra V, Dierkhising RA, Collazo-Clavell ML, Talley NJ, Clark MM. Gastric antral injections of botulinum toxin delay gastric emptying but do not reduce body weight. Clin Gastroenterol Hepatol. 2013 Feb; 11(2):145-50.e1. Epub 2012 Oct 09. 2277550
    View PubMed
  3. Leggett CL, Nelsen EM, Tian J, Schleck CB, Zinsmeister AR, Dunagan KT, Locke GR 3rd, Wang KK, Talley NJ, Iyer PG. Metabolic syndrome as a risk factor for barrett esophagus: a population-based case-control study. Mayo Clin Proc. 2013 Feb; 88(2):157-65. 2300847
    View PubMed
  4. Flook NW, Moayyedi P, Dent J, Talley NJ, Persson T, Karlson BW, Ruth M. Acid-suppressive therapy with esomeprazole for relief of unexplained chest pain in primary care: a randomized, double-blind, placebo-controlled trial. Am J Gastroenterol. 2013 Jan; 108(1):56-64. Epub 2012 Nov 13. 2300509
    View PubMed
  5. Choung RS, Locke GR III, Schleck CD, Ziegenfuss JY, Beebe TJ, Zinsmeister AR, Talley NJ. A low response rate does not necessarily indicate non-response bias in gastroenterology survey research: A population-based study. Journal of Public Health (Germany). 2013; 21(1):87-95. 2303962
  6. Rajan E, Gostout CJ, Aimore Bonin E, Moran EA, Locke RG, Szarka LA, Talley NJ, Deters JL, Miller CA, Knipschield MA, Lurken MS, Stoltz GJ, Bernard CE, Grover M, Farrugia G. Endoscopic full-thickness biopsy of the gastric wall with defect closure by using an endoscopic suturing device: survival porcine study. Gastrointest Endosc. 2012 Nov; 76(5):1014-9. 2278385
    View PubMed
  7. Saito YA, Larson JJ, Atkinson EJ, Ryu E, Almazar AE, Petersen GM, Talley NJ. The role of 5-HTT LPR and GNbeta3 825C>T polymorphisms and gene-environment interactions in irritable bowel syndrome (IBS). Dig Dis Sci. 2012 Oct; 57(10):2650-7. Epub 2012 Aug 2 2261692
    View PubMed
  8. Talley NJ. Dietary modification as a treatment for irritable bowel syndrome. Gastroenterol Hepatol (N Y). 2012 Aug; 8(8):552-4. 2276685
    View PubMed
  9. Alexander JA, Jung KW, Arora AS, Enders F, Katzka DA, Kephardt GM, Kita H, Kryzer LA, Romero Y, Smyrk TC, Talley NJ. Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2012 Jul; 10(7):742-749.e1. Epub 2012 Apr 01. 2236793
    View PubMed
  10. Myasoedova E, Matteson EL, Talley NJ, Crowson CS. Increased incidence and impact of upper and lower gastrointestinal events in patients with rheumatoid arthritis in Olmsted County, Minnesota: a longitudinal population-based study. J Rheumatol. 2012 Jul; 39(7):1355-62. Epub 2012 Apr 01. 2236797
    View PubMed
  11. Lacy BE, Talley NJ, Locke GR 3rd, Bouras EP, DiBaise JK, El-Serag HB, Abraham BP, Howden CW, Moayyedi P, Prather C. Review article: current treatment options and management of functional dyspepsia. Aliment Pharmacol Ther. 2012 Jul; 36(1):3-15. Epub 2012 May 16. 2254236
    View PubMed
  12. Herrick LM, Locke GR 3rd, Zinsmeister AR, Talley NJ. Challenges and lessons learned in conducting comparative-effectiveness trials. Am J Gastroenterol. 2012 May; 107(5):644-9. 2242192
    View PubMed
  13. Lee J, Huprich J, Kujath C, Ravi K, Enders F, Smyrk TC, Katzka DA, Talley NJ, Alexander JA. Esophageal diameter is decreased in some patients with eosinophilic esophagitis and might increase with topical corticosteroid therapy. Clin Gastroenterol Hepatol. 2012 May; 10(5):481-6. Epub 2012 Feb 3. 2223074
    View PubMed
  14. Talley NJ, Locke GR 3rd, Herrick LM, Silvernail VM, Prather CM, Lacy BE, DiBaise JK, Howden CW, Brenner DM, Bouras EP, El-Serag HB, Abraham BP, Moayyedi P, Zinsmeister AR. Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics. Contemp Clin Trials. 2012 May; 33(3):523-33. Epub 2012 Feb 10. 2226766
    View PubMed
  15. Choung RS, Locke GR 3rd, Rey E, Schleck CD, Baum C, Zinsmeister AR, Talley NJ. Factors associated with persistent and nonpersistent chronic constipation, over 20 years. Clin Gastroenterol Hepatol. 2012 May; 10(5):494-500. Epub 2012 Jan 28. 2220972
    View PubMed
  16. Adibi P, Keshteli AH, Esmaillzadeh A, Afshar H, Roohafza H, Bagherian-Sararoudi R, Daghaghzadeh H, Soltanian N, Feinle-Bisset C, Boyce P, Talley NJ. The study on the epidemiology of psychological, alimentary health and nutrition (SEPAHAN): overview of methodology. Journal Of Research In Medical Sciences. 2012 Mar; 17:S292-8. 2273136
  17. Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Overlap of dyspepsia and gastroesophageal reflux in the general population: one disease or distinct entities? Neurogastroenterol Motil. 2012 Mar; 24(3):229-34, e106. Epub 2011 Dec 12. 2210924
    View PubMed
  18. Choung RS, Locke GR 3rd, Lee RM, Schleck CD, Zinsmeister AR, Talley NJ. Cyclic vomiting syndrome and functional vomiting in adults: association with cannabinoid use in males. Neurogastroenterol Motil. 2012 Jan; 24(1):20-6, e1. Epub 2011 Sep 27. 2196993
    View PubMed
  19. Brook RA, Kleinman NL, Choung RS, Smeeding JE, Talley NJ. Excess comorbidity prevalence and cost associated with functional dyspepsia in an employed population. Dig Dis Sci. 2012 Jan; 57(1):109-18. Epub 2011 Jul 13. 2221672
    View PubMed
  20. Rey E, Choung RS, Schleck CD, Zinsmeister AR, Talley NJ, Locke GR 3rd. Prevalence of hidden gastroparesis in the community: the gastroparesis "iceberg". J Neurogastroenterol Motil. 2012 Jan; 18(1):34-42. Epub 2012 Jan 16. 2224216
    View PubMed
  21. Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Melton LJ 3rd, Talley NJ. Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population. Am J Gastroenterol. 2012 Jan; 107(1):82-8. Epub 2011 Nov 15. 2206812
    View PubMed
  22. Tack J, Talley NJ. [In process citation]. Arq Gastroenterol. 2012; 49 Suppl 1:21-7. 2300540
    View PubMed
  23. Chang JY, Talley NJ, Locke GR 3rd, Katzka DA, Schleck CD, Zinsmeister AR, Dunagan KT, Wu TT, Wang KK, Prasad GA. Population screening for barrett esophagus: a prospective randomized pilot study. Mayo Clin Proc. 2011 Dec; 86(12):1174-80. 2208547
    View PubMed
  24. van Zanten SV, Wahlqvist P, Talley NJ, Halling K, Vakil N, Lauritsen K, Flook N, Persson T, Bolling-Sternevald E, STARS II Investigators. Randomised clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole--results from the STARS II study. Aliment Pharmacol Ther. 2011 Oct; 34(7):714-23. Epub 2011 Aug 17. 2199680
    View PubMed
  25. Walker MM, Talley NJ. Clinical value of duodenal biopsies--beyond the diagnosis of coeliac disease. Pathol Res Pract. 2011 Sep 15; 207(9):538-44. Epub 2011 Sep 22. 2203984
    View PubMed
  26. Jung KW, Talley NJ, Romero Y, Katzka DA, Schleck CD, Zinsmeister AR, Dunagan KT, Lutzke LS, Wu TT, Wang KK, Frederickson M, Geno DM, Locke GR, Prasad GA. Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study. Am J Gastroenterol. 2011 Aug; 106(8):1447-55; quiz 1456. Epub 2011 Apr 12. 2157369
    View PubMed
  27. Ravi K, Talley NJ, Smyrk TC, Katzka DA, Kryzer L, Romero Y, Arora AS, Alexander JA. Low grade esophageal eosinophilia in adults: an unrecognized part of the spectrum of eosinophilic esophagitis? Dig Dis Sci. 2011 Jul; 56(7):1981-6. Epub 2011 Feb 06. 2147449
    View PubMed
  28. Katz KD, Rashtak S, Lahr BD, Melton LJ 3rd, Krause PK, Maggi K, Talley NJ, Murray JA. Screening for celiac disease in a North American population: sequential serology and gastrointestinal symptoms. Am J Gastroenterol. 2011 Jul; 106(7):1333-9. Epub 2011 Mar 01. 2179685
    View PubMed
  29. Achem SR, Almansa C, Krishna M, Heckman MG, Wolfsen HC, Talley NJ, DeVault KR. Oesophageal eosinophilic infiltration in patients with noncardiac chest pain. Aliment Pharmacol Ther. 2011 Jun; 33(11):1194-201. Epub 2011 Apr 05. 2157426
    View PubMed
  30. Talley NJ. Irritable bowel syndrome: rational therapy. Consultant. 2011 Jun; 51(6):341-7. 2179706
  31. Pittock SJ, Lennon VA, Dege CL, Talley NJ, Locke GR 3rd. Neural autoantibody evaluation in functional gastrointestinal disorders: a population-based case-control study. Dig Dis Sci. 2011 May; 56(5):1452-9. Epub 2010 Dec 23. 2136055
    View PubMed
  32. Choung RS, Ruff KC, Malhotra A, Herrick L, Locke GR 3rd, Harmsen WS, Zinsmeister AR, Talley NJ, Saito YA. Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. Aliment Pharmacol Ther. 2011 May; 33(9):1059-67. Epub 2011 Mar 13. 2152026
    View PubMed
  33. Talley NJ, Abreu MT, Achkar JP, Bernstein CN, Dubinsky MC, Hanauer SB, Kane SV, Sandborn WJ, Ullman TA, Moayyedi P, American College of Gastroenterology IBD Task Force. An evidence-based systematic review on medical therapies for inflammatory bowel disease. Am J Gastroenterol. 2011 Apr; 106 Suppl 1:S2-25; quiz S26. 2188493
    View PubMed
  34. Ford AC, Achkar JP, Khan KJ, Kane SV, Talley NJ, Marshall JK, Moayyedi P. Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis. Am J Gastroenterol. 2011 Apr; 106(4):601-16. Epub 2011 Mar 15. 2164078
    View PubMed
  35. Ford AC, Kane SV, Khan KJ, Achkar JP, Talley NJ, Marshall JK, Moayyedi P. Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis. Am J Gastroenterol. 2011 Apr; 106(4):617-29. Epub 2011 Mar 15. 2164079
    View PubMed
  36. Wang YR, Talley NJ, Picco MF. Overlap irritable bowel syndrome, inflammatory bowel disease, and diverticular disease. J Clin Gastroenterol. 2011 Apr; 45(Suppl 1):S36-42. 2162459
  37. Beebe TJ, Ziegenfuss JY, St Sauver JL, Jenkins SM, Haas L, Davern ME, Talley NJ. Health Insurance Portability and Accountability Act (HIPAA) authorization and survey nonresponse bias. Med Care. 2011 Apr; 49(4):365-70. 2151638
    View PubMed
  38. Dinning PG, Jones M, Hunt L, Fuentealba SE, Kalanter J, King DW, Lubowski DZ, Talley NJ, Cook IJ. Factor analysis identifies subgroups of constipation. World J Gastroenterol. 2011 Mar 21; 17(11):1468-74. 2164034
    View PubMed
  39. Spergel JM, Book WM, Mays E, Song L, Shah SS, Talley NJ, Bonis PA. Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States. J Pediatr Gastroenterol Nutr. 2011 Mar; 52(3):300-6. 2124120
    View PubMed
  40. Ang D, Talley NJ, Simren M, Janssen P, Boeckxstaens G, Tack J. Review article: endpoints used in functional dyspepsia drug therapy trials. Aliment Pharmacol Ther. 2011 Mar; 33(6):634-49. Epub 2011 Jan 12. 2141641
    View PubMed
  41. Talley NJ. Rumination syndrome. Gastroenterol Hepatol (N Y). 2011 Feb; 7(2):117-8. 2157469
    View PubMed
  42. Choung RS, Shah ND, Chitkara D, Branda ME, Van Tilburg MA, Whitehead WE, Katusic SK, Locke GR 3rd, Talley NJ. Direct medical costs of constipation from childhood to early adulthood: a population-based birth cohort study. J Pediatr Gastroenterol Nutr. 2011 Jan; 52(1):47-54. 2118537
    View PubMed
  43. Chang JY, Talley NJ. An update on irritable bowel syndrome: from diagnosis to emerging therapies. Curr Opin Gastroenterol. 2011 Jan; 27(1):72-8. 2125622
    View PubMed
  44. Choung RS, Branda ME, Chitkara D, Shah ND, Katusic SK, Locke GR 3rd, Talley NJ. Longitudinal direct medical costs associated with constipation in women. Aliment Pharmacol Ther. 2011 Jan; 33(2):251-60. Epub 2010 Nov 22. 2125539
    View PubMed
  45. Jung KW, Gundersen N, Kopacova J, Arora AS, Romero Y, Katzka D, Francis D, Schreiber J, Dierkhising RA, Talley NJ, Smyrk TC, Alexander JA. Occurrence of and risk factors for complications after endoscopic dilation in eosinophilic esophagitis. Gastrointest Endosc. 2011 Jan; 73(1):15-21. Epub 2010 Nov 09. 2141719
    View PubMed
  46. Myasoedova E, Talley NJ, Manek NJ, Crowson CS. Prevalence and risk factors of gastrointestinal disorders in patients with rheumatoid arthritis: results from a population-based survey in olmsted county, Minnesota. Gastroenterol Res Pract. 2011; 2011:745829. Epub 2011 Nov 17. 2209898
    View PubMed
  47. Lacy BE, Talley NJ, Camilleri M. Functional dyspepsia: time to change clinical trial design? Am J Gastroenterol. 2010 Dec; 105(12):2525-9. 2136392
    View PubMed
  48. Choung RS, Herrick LM, Locke GR 3rd, Zinsmeister AR, Talley NJ. Irritable bowel syndrome and chronic pelvic pain: a population-based study. J Clin Gastroenterol. 2010 Nov-Dec; 44(10):696-701. 1995611
    View PubMed
  49. Aro P, Ronkainen J, Storskrubb T, Vieth M, Engstrand L, Johansson SE, Bolling-Sternevald E, Bolinder G, Alving K, Talley NJ, Agreus L. Use of tobacco products and gastrointestinal morbidity: an endoscopic population-based study (the Kalixanda study). Eur J Epidemiol. 2010 Oct; 25(10):741-50. Epub 2010 Jul 29. 2129995
    View PubMed
  50. McElhiney J, Lohse MR, Arora AS, Peloquin JM, Geno DM, Kuntz MM, Enders FB, Fredericksen M, Abdalla AA, Khan Y, Talley NJ, Diehl NN, Beebe TJ, Harris AM, Farrugia G, Graner DE, Murray JA, Locke GR 3rd, Grothe RM, Crowell MD, Francis DL, Grudell AM, The Mayo Dysphagia Questionnaire-30: documentation of reliability and validity of a tool for interventional trials in adults with esophageal disease. Dysphagia. 2010 Sep; 25(3):221-30. Epub 2009 Oct 24. 1969618
    View PubMed
  51. Chang JY, Choung RS, Lee RM, Locke GR 3rd, Schleck CD, Zinsmeister AR, Smyrk TC, Talley NJ. A shift in the clinical spectrum of eosinophilic gastroenteritis toward the mucosal disease type. Clin Gastroenterol Hepatol. 2010 Aug; 8(8):669-75; quiz e88. Epub 2010 May 06. 1999736
    View PubMed
  52. Walker MM, Murray JA, Ronkainen J, Aro P, Storskrubb T, D'Amato M, Lahr B, Talley NJ, Agreus L. Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a population-based study. Gastroenterology. 2010 Jul; 139(1):112-9. Epub 2010 Apr 13. 2106875
    View PubMed
  53. Chang JY, Talley NJ. Current and emerging therapies in irritable bowel syndrome: from pathophysiology to treatment. Trends Pharmacol Sci. 2010 Jul; 31(7):326-34. Epub 2010 Jun 01. 2101859
    View PubMed
  54. Rey E, Locke GR 3rd, Jung HK, Malhotra A, Choung RS, Beebe TJ, Schleck CD, Zinsmeister AR, Talley NJ. Measurement of abdominal symptoms by validated questionnaire: a 3-month recall timeframe as recommended by Rome III is not superior to a 1-year recall timeframe. Aliment Pharmacol Ther. 2010 Jun; 31(11):1237-47. Epub 2010 Mar 06. 1990445
    View PubMed
  55. Walker MM, Salehian SS, Murray CE, Rajendran A, Hoare JM, Negus R, Powell N, Talley NJ. Implications of eosinophilia in the normal duodenal biopsy - an association with allergy and functional dyspepsia. Aliment Pharmacol Ther. 2010 Jun; 31(11):1229-36. Epub 2010 Mar 04. 2102195
    View PubMed
  56. Gururatsakul M, Holloway RH, Talley NJ, Holtmann GJ. Association between clinical manifestations of complicated and uncomplicated peptic ulcer and visceral sensory dysfunction. J Gastroenterol Hepatol. 2010 Jun; 25(6):1162-9. 2103777
    View PubMed
  57. Brook RA, Kleinman NL, Choung RS, Melkonian AK, Smeeding JE, Talley NJ. Functional dyspepsia impacts absenteeism and direct and indirect costs. Clin Gastroenterol Hepatol. 2010 Jun; 8(6):498-503. Epub 2010 Mar 19. 2103605
    View PubMed
  58. Walter SA, Kjellstrom L, Nyhlin H, Talley NJ, Agreus L. Assessment of normal bowel habits in the general adult population: the Popcol study. Scand J Gastroenterol. 2010 May; 45(5):556-66. 1999564
    View PubMed
  59. Saito YA, Petersen GM, Larson JJ, Atkinson EJ, Fridley BL, de Andrade M, Locke GR 3rd, Zimmerman JM, Almazar-Elder AE, Talley NJ. Familial aggregation of irritable bowel syndrome: a family case-control study. Am J Gastroenterol. 2010 Apr; 105(4):833-41. Epub 2010 Mar 16. 2148632
    View PubMed
  60. Tack J, Talley NJ. Gastroduodenal disorders. Am J Gastroenterol. 2010 Apr; 105(4):757-63. 1997966
    View PubMed
  61. Leise MD, Locke GR 3rd, Dierkhising RA, Zinsmeister AR, Reeder GS, Talley NJ. Patients dismissed from the hospital with a diagnosis of noncardiac chest pain: cardiac outcomes and health care utilization. Mayo Clin Proc. 2010 Apr; 85(4):323-30. Epub 2010 Mar 01. 1990537
    View PubMed
  62. Chang JY, Locke GR 3rd, McNally MA, Halder SL, Schleck CD, Zinsmeister AR, Talley NJ. Impact of functional gastrointestinal disorders on survival in the community. Am J Gastroenterol. 2010 Apr; 105(4):822-32. Epub 2010 Feb 16. 1987812
    View PubMed
  63. Rubio-Tapia A, Talley NJ, Gurudu SR, Wu TT, Murray JA. Gluten-free diet and steroid treatment are effective therapy for most patients with collagenous sprue. Clin Gastroenterol Hepatol. 2010 Apr; 8(4):344-349.e3. Epub 2010 Jan 06. 1980519
    View PubMed
  64. Jung HK, Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Diarrhea-predominant irritable bowel syndrome is associated with diverticular disease: a population-based study. Am J Gastroenterol. 2010 Mar; 105(3):652-61. Epub 2009 Oct 27. 1969599
    View PubMed
  65. Gururatsakul M, Holloway RH, Adam B, Liebregts T, Talley NJ, Holtmann GJ. The ageing gut: diminished symptom response to a standardized nutrient stimulus. Neurogastroenterol Motil. 2010 Mar; 22(3):246-e77. Epub 2009 Oct 08. 1988062
    View PubMed
  66. Haag S, Senf W, Tagay S, Heuft G, Gerken G, Talley NJ, Holtmann G. Is there any association between disturbed gastrointestinal visceromotor and sensory function and impaired quality of life in functional dyspepsia? Neurogastroenterol Motil. 2010 Mar; 22(3):262-e79. Epub 2009 Oct 08. 1988063
    View PubMed
  67. Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, Brandt LJ, Quigley EM. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut. 2010 Mar; 59(3):325-32. Epub 2008 Dec 17. 1995799
    View PubMed
  68. Powell N, Walker MM, Talley NJ. Gastrointestinal eosinophils in health, disease and functional disorders. Nat Rev Gastroenterol Hepatol. 2010 Mar; 7(3):146-56. Epub 2010 Feb 02. 1995774
    View PubMed
  69. Rey E, Choung RS, Schleck CD, Zinsmeister AR, Locke GR 3rd, Talley NJ. Onset and risk factors for fecal incontinence in a US community. Am J Gastroenterol. 2010 Feb; 105(2):412-9. Epub 2009 Oct 20. 1969670
    View PubMed
  70. Kephart GM, Alexander JA, Arora AS, Romero Y, Smyrk TC, Talley NJ, Kita H. Marked deposition of eosinophil-derived neurotoxin in adult patients with eosinophilic esophagitis. Am J Gastroenterol. 2010 Feb; 105(2):298-307. Epub 2009 Nov 03. 1971367
    View PubMed
  71. Ford AC, Guyatt GH, Talley NJ, Moayyedi P. Errors in the conduct of systematic reviews of pharmacological interventions for irritable bowel syndrome. Am J Gastroenterol. 2010 Feb; 105(2):280-8. Epub 2009 Nov 17. 1988250
    View PubMed
  72. Cremonini F, Camilleri M, Clark MM, Beebe TJ, Locke GR, Zinsmeister AR, Herrick LM, Talley NJ. "Associations among binge eating behavior patterns and gastrointestinal symptoms: A population-based study": Corrigendum. Int J Obes. 2010 Jan; 34(1):214. 2164071
  73. Saito YA, Rey E, Almazar-Elder AE, Harmsen WS, Zinsmeister AR, Locke GR, Talley NJ. A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome. Am J Gastroenterol. 2010 Jan; 105(1):170-7. Epub 2009 Oct 06. 1966692
    View PubMed
  74. Zhang L, Eslick GD, Xia HH, Wu C, Phung N, Talley NJ. Relationship between alcohol consumption and active Helicobacter pylori infection. Alcohol Alcohol. 2010 Jan-Feb; 45(1):89-94. Epub 2009 Oct 06. 1982720
    View PubMed
  75. Talley NJ, Herrick L, Locke GR. Editorial: Antidepressants in functional dyspepsia. Expert rev. gastroenterol. Hepatol. 2010; 4(1):5-8. 2102216
    View PubMed
  76. Beebe TJ, Rey E, Ziegenfuss JY, Jenkins S, Lackore K, Talley NJ, Locke RG 3rd. Shortening a survey and using alternative forms of prenotification: impact on response rate and quality. BMC Med Res Methodol. 2010; 10:50. Epub 2010 Jun 08. 2103503
    View PubMed
  77. Jung HK, Choung RS, Talley NJ. Response to Dr Tursi. Am J Gastroenterol. 2010; 105(10):2293-4. 2121400
  78. Tack J, Talley NJ. Gastroduodenal disorders. Rev Gastroenterol Mex. 2010; 75(4):463-71. 2273120
  79. Talley NJ. Response to mangel. Am J Gastroenterol. 2009 Dec; 104(12):3106. 1975555
    View PubMed
  80. Cook IJ, Talley NJ, Benninga MA, Rao SS, Scott SM. Chronic constipation: overview and challenges. Neurogastroenterol Motil. 2009 Dec; 21 Suppl 2:1-8. 1969954
    View PubMed
  81. Emmanuel AV, Tack J, Quigley EM, Talley NJ. Pharmacological management of constipation. Neurogastroenterol Motil. 2009 Dec; 21 Suppl 2:41-54. 1969955
    View PubMed
  82. Ford AC, Spiegel BM, Talley NJ, Moayyedi P. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2009 Dec; 7(12):1279-86. Epub 2009 Aug 12. 1982694
    View PubMed
  83. Spiegel B, Camilleri M, Bolus R, Andresen V, Chey WD, Fehnel S, Mangel A, Talley NJ, Whitehead WE. Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: a Rome Foundation report. Gastroenterology. 2009 Dec; 137(6):1944-53.e1-3. Epub 2009 Aug 23. 1978932
    View PubMed
  84. Talley NJ. So you aspire to be a Professor? World J Gastroenterol. 2009 Nov 28; 15(44):5626-5627. 1978254
    View PubMed
  85. Rey E, Talley NJ. Irritable bowel syndrome: novel views on the epidemiology and potential risk factors. Dig Liver Dis. 2009 Nov; 41(11):772-80. Epub 2009 Aug 08. 1957544
    View PubMed
  86. Kennedy AT, Weiser KT, Crowell MD, Talley NJ, Lacy BE. Functional dyspepsia: Validation and results of a novel survey instrument to evaluate patient knowledge and perceptions. J Clin Gastroenterol. 2009 Nov-Dec; 43(10):933-40. 1939160
    View PubMed
  87. Eslick GD, Kalantar JS, Talley NJ. Rectal bleeding: epidemiology, associated risk factors, and health care seeking behaviour: a population-based study. Colorectal Dis. 2009 Nov; 11(9):921-6. Epub 2008 Oct 21. 1970034
    View PubMed
  88. Talley NJ, Choung RS. Whither dyspepsia? A historical perspective of functional dyspepsia, and concepts of pathogenesis and therapy in 2009. J Gastroenterol Hepatol. 2009 Oct; 24 Suppl 3:S20-8. 1967362
    View PubMed
  89. Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R, Talley NJ, Lam SK, Xiao SD, Tan HJ, Wu CY, Jung HC, Hoang BH, Kachintorn U, Goh KL, Chiba T, Rani AA, Second Asia-Pacific Conference. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol. 2009 Oct; 24(10):1587-600. 1981975
    View PubMed
  90. Jiang X, Locke GR, Zinsmeister AR, Schleck CD, Talley NJ. Health care seeking for abdominal bloating and visible distention. Aliment Pharmacol Ther. 2009 Oct; 30(7):775-83. Epub 2009 Jun 25. 1959597
    View PubMed
  91. Prasad GA, Alexander JA, Schleck CD, Zinsmeister AR, Smyrk TC, Elias RM, Locke GR 3rd, Talley NJ. Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol. 2009 Oct; 7(10):1055-61. Epub 2009 Jul 01. 1952617
    View PubMed
  92. Saito YA, Talley NJ. AJG series: molecular biology for clinicians. Am J Gastroenterol. 2009 Oct; 104(10):2583-7. Epub 2009 Jun 23. 1949805
    View PubMed
  93. Chang JY, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Risk factors for chronic diarrhoea in the community in the absence of irritable bowel syndrome. Neurogastroenterol Motil. 2009 Oct; 21(10):1060-e87. Epub 2009 May 21. 1944210
    View PubMed
  94. DeVault KR, Talley NJ. Insights into the future of gastric acid suppression. Nat Rev Gastroenterol Hepatol. 2009 Sep; 6(9):524-32. 1959582
    View PubMed
  95. Gathaiya N, Locke GR 3rd, Camilleri M, Schleck CD, Zinsmeister AR, Talley NJ. Novel associations with dyspepsia: a community-based study of familial aggregation, sleep dysfunction and somatization. Neurogastroenterol Motil. 2009 Sep; 21(9):922-e69. Epub 2009 Jun 02. 1978319
    View PubMed
  96. Talley NJ. Step-up and step-down treatment strategies did not differ for symptom relief at 6 months in new onset dyspepsia. Evid Based Med. 2009 Aug; 14(4):114. 1956972
    View PubMed
  97. Aro P, Talley NJ, Ronkainen J, Storskrubb T, Vieth M, Johansson SE, Bolling-Sternevald E, Agreus L. Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology. 2009 Jul; 137(1):94-100. Epub 2009 Mar 26. 1965472
    View PubMed
  98. Vakil N, Talley N, van Zanten SV, Flook N, Persson T, Bjorck E, Lind T, Bolling-Sternevald E, STARS I Study Group. Cost of detecting malignant lesions by endoscopy in 2741 primary care dyspeptic patients without alarm symptoms. Clin Gastroenterol Hepatol. 2009 Jul; 7(7):756-61. Epub 2009 Apr 10. 1981947
    View PubMed
  99. Choung RS, Locke GR 3rd, Zinsmeister AR, Schleck CD, Talley NJ. Psychosocial distress and somatic symptoms in community subjects with irritable bowel syndrome: a psychological component is the rule. Am J Gastroenterol. 2009 Jul; 104(7):1772-9. Epub 2009 Jun 02. 1946939
    View PubMed
  100. Talley NJ. Green light from the FDA for new drug development in irritable bowel syndrome and functional dyspepsia. Am J Gastroenterol. 2009 Jun; 104(6):1339-41. 1946938
    View PubMed
  101. Choung RS, Locke GR 3rd, Zinsmeister AR, Schleck CD, Talley NJ. Opioid bowel dysfunction and narcotic bowel syndrome: a population-based study. Am J Gastroenterol. 2009 May; 104(5):1199-204. Epub 2009 Apr 14. 1937441
    View PubMed
  102. Goodwin RD, Keyes KM, Stein MB, Talley NJ. Peptic ulcer and mental disorders among adults in the community: the role of nicotine and alcohol use disorders. Psychosom Med. 2009 May; 71(4):463-8. 1962568
    View PubMed
  103. Walker MM, Talley NJ, Prabhakar M, Pennaneac'h CJ, Aro P, Ronkainen J, Storskrubb T, Harmsen WS, Zinsmeister AR, Agreus L. Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther. 2009 Apr 1; 29(7):765-73. Epub 2009 Jan 17. 1920538
    View PubMed
  104. Jung HK, Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Szarka LA, Mullan B, Talley NJ. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology. 2009 Apr; 136(4):1225-33. Epub 2008 Dec 24. 1928106
    View PubMed
  105. Almansa C, Krishna M, Buchner AM, Ghabril MS, Talley N, DeVault KR, Wolfsen H, Raimondo M, Guarderas JC, Achem SR. Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults. Am J Gastroenterol. 2009 Apr; 104(4):828-33. Epub 2009 Feb 24. 1926246
    View PubMed
  106. Cremonini F, Camilleri M, Clark MM, Beebe TJ, Locke GR, Zinsmeister AR, Herrick LM, Talley NJ. Associations among binge eating behavior patterns and gastrointestinal symptoms: a population-based study. Int J Obes (Lond). 2009 Mar; 33(3):342-53. Epub 2009 Jan 13. 1914901
    View PubMed
  107. Talley NJ, Seon Choung R. Functional (non-ulcer) dyspepsia and gastroparesis--differentiating these conditions and practical management approaches. Rev Gastroenterol Disord. 2009 Spring; 9(2):E48-53. 1957533
    View PubMed
  108. Eslick GD, Talley NJ. Gastroesophageal reflux disease (GERD): risk factors, and impact on quality of life-a population-based study. J Clin Gastroenterol. 2009 Feb; 43(2):111-7. 1915566
    View PubMed
  109. Cremonini F, Camilleri M, Zinsmeister AR, Herrick LM, Beebe T, Talley NJ. Sleep disturbances are linked to both upper and lower gastrointestinal symptoms in the general population. Neurogastroenterol Motil. 2009 Feb; 21(2):128-35. Epub 2008 Sep 18. 1914574
    View PubMed
  110. Saito YA, Strege PR, Tester DJ, Locke GR 3rd, Talley NJ, Bernard CE, Rae JL, Makielski JC, Ackerman MJ, Farrugia G. Sodium channel mutation in irritable bowel syndrome: evidence for an ion channelopathy. Am J Physiol Gastrointest Liver Physiol. 2009 Feb; 296(2):G211-8. Epub 2008 Dec 04. 1900193
    View PubMed
  111. Hart J, Hawkey CJ, Lanas A, Naesdal J, Talley NJ, Thomson ABR, Yeomans ND. Predictors of gastroduodenal erosions in patients taking low-dose aspirin. Aliment Pharmacol Ther. 2009 Jan 1; 31(1):143-9. 1978945
    View PubMed
  112. American College of Gastroenterology Task Force on Irritable Bowel Syndrome, Brandt LJ, Chey WD, Foxx-Orenstein AE, Schiller LR, Schoenfeld PS, Spiegel BM, Talley NJ, Quigley EM. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol. 2009 Jan; 104 Suppl 1:S1-35. 1966737
    View PubMed
  113. Talley NJ, Lasch KL, Baum CL. A gap in our understanding: chronic constipation and its comorbid conditions. Clin Gastroenterol Hepatol. 2009 Jan; 7(1):9-19. Epub 2008 Oct 01. 1915585
    View PubMed
  114. Agreus L, Storskrubb T, Aro P, Ronkainen J, Talley NJ, Sipponen P. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population. Scand J Gastroenterol. 2009; 44(5):564-70. 1962343
    View PubMed
  115. Rex DK, Talley NJ, Katz PO, Sandborn WJ, Hanauer SB. Report From the ACG: Highlights of the 72nd Annual Scientific Meeting of the American College of Gastroenterology, October 12-17, 2007, Philadelphia, PA. Rev Gastroenterol Disord. 2008 Winter; 8(1):42-57. 1910971
  116. Talley NJ. Placebo acupuncture improved symptoms and quality of life in irritable bowel syndrome. Evid Based Med. 2008 Dec; 13(6):180. 1915277
    View PubMed
  117. Ford AC, Talley NJ, Spiegel BMR, Foxx-Orenstein AE, Schiller L, Quigley EMM, Moayyedi P. Effect of fibre, antispasmodics and peppermint oil in the treatment of irritable bowel syndrome: system review and meta-analysis. BMJ. 2008 Nov 13; 337:A2313. 1911699
  118. Bunch TJ, Packer DL, Jahangir A, Locke GR, Talley NJ, Gersh BJ, Roy RR, Hodge DO, Asirvatham SJ. Long-term risk of atrial fibrillation with symptomatic gastroesophageal reflux disease and esophagitis. Am J Cardiol. 2008 Nov 1; 102(9):1207-11. Epub 2008 Aug 27. 1901230
    View PubMed
  119. Talley NJ. Genetics and functional bowel disease. J Pediatr Gastroenterol Nutr. 2008 Nov; 47(5):680-2. 1915473
    View PubMed
  120. Talley NJ. Subdividing functional dyspepsia: a paradigm shift? Gut. 2008 Nov; 57(11):1487-9. 1911518
    View PubMed
  121. Ford AC, Veldhuyzen van Zanten SJ, Rodgers CC, Talley NJ, Vakil NB, Moayyedi P. Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis. Gut. 2008 Nov; 57(11):1545-53. Epub 2008 Aug 01. 1911314
    View PubMed
  122. Chitkara DK, Talley NJ, Schleck C, Zinsmeister AR, Shah ND, Locke GR. Recollection of childhood abdominal pain in adults with functional gastrointestinal disorders. Scan J Gastroenterol. 2008 Nov:1-7. 1869549
  123. Ford AC, Talley NJ, Veldhuyzen van Zanten SJ, Vakil NB, Simel DL, Moayyedi P. Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms? JAMA. 2008 Oct 15; 300(15):1793-805. 1990430
    View PubMed
  124. Crane SJ, Locke GR 3rd, Harmsen WS, Zinsmeister AR, Romero Y, Talley NJ. Survival trends in patients with gastric and esophageal adenocarcinomas: a population-based study. Mayo Clin Proc. 2008 Oct; 83(10):1087-94. 1904607
    View PubMed
  125. Pilichiewicz AN, Feltrin KL, Horowitz M, Holtmann G, Wishart JM, Jones KL, Talley NJ, Feinle-Bisset C. Functional dyspepsia is associated with a greater symptomatic response to fat but not carbohydrate, increased fasting and postprandial CCK, and diminished PYY. Am J Gastroenterol. 2008 Oct; 103(10):2613-23. Epub 2008 Sep 04. 1955098
    View PubMed
  126. Talley NJ. Reply to Dr. Kittisupamongkol. Am J Gastroenterol. 2008 Sep 04. [Epub ahead of print] 1915686
    View PubMed
  127. Eslick GD, Talley NJ. Natural history and predictors of outcome for non-cardiac chest pain: a prospective 4-year cohort study. Neurogastroenterol Motil. 2008 Sep; 20(9):989-97. Epub 2008 May 06. 1911311
    View PubMed
  128. Quan C, Talley NJ, Jones MP, Howell S, Horowitz M. Gastrointestinal symptoms and glycemic control in diabetes mellitus: a longitudinal population study. Eur J Gastroenterol Hepatol. 2008 Sep; 20(9):888-97. 1955196
    View PubMed
  129. Talley NJ. RESPONSE TO THE LETTER. Am J Gastroenterol. 2008 Aug 27. [Epub ahead of print] 1915710
    View PubMed
  130. Talley NJ. Is it time to screen and treat H pylori to prevent gastric cancer? Lancet. 2008 Aug 2; 372(9636):350-2. 1892666
    View PubMed
  131. McNally MA, Locke GR, Zinsmeister AR, Schleck CD, Peterson J, Talley NJ. Biliary events and an increased risk of new onset irritable bowel syndrome: a population-based cohort study. Aliment Pharmacol Ther. 2008 Aug 1; 28(3):334-43. 1915098
    View PubMed
  132. Vakil N, Laine L, Talley NJ, Zakko SF, Tack J, Chey WD, Kralstein J, Earnest DL, Ligozio G, Cohard-Radice M. Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials. Am J Gastroenterol. 2008 Aug; 103(8):1906-19. Epub 2008 Jul 04. 1910979
    View PubMed
  133. Quan C, Talley NJ, Jones MP, Spies J, Horowitz M. Gain and loss of gastrointestinal symptoms in diabetes mellitus: associations with psychiatric disease, glycemic control, and autonomic neuropathy over 2 years of follow-up. Am J Gastroenterol. 2008 Aug; 103(8):2023-30. 1910980
    View PubMed
  134. Jones MP, Talley NJ, Eslick GD, Dubois D, Tack J. Community subgroups in dyspepsia and their association with weight loss. Am J Gastroenterol. 2008 Aug; 103(8):2051-60. 1910981
    View PubMed
  135. Bouras EP, Talley NJ, Camilleri M, Burton DD, Heckman MG, Crook JE, Richelson E. Effects of amitriptyline on gastric sensorimotor function and postprandial symptoms in healthy individuals: a randomized, double-blind, placebo-controlled trial. Am J Gastroenterol. 2008 Aug; 103(8):2043-50. 1904610
    View PubMed
  136. Saito YA, Talley NJ. Genetics of irritable bowel syndrome. Am J Gastroenterol. 2008 Aug; 103(8):2100-4; quiz 2105. Epub 2008 Jul 05. 1904612
    View PubMed
  137. Rajan E, Gostout CJ, Lurken MS, Talley NJ, Locke GR, Szarka LA, Sumiyama K, Bakken TA, Stoltz GJ, Knipschield MA, Farrugia G. Endoscopic "no hole" full-thickness biopsy of the stomach to detect myenteric ganglia. Gastrointest Endosc. 2008 Aug; 68(2):301-7. Epub 2008 Feb 11. 1889881
    View PubMed
  138. Saito YA, Zimmerman JM, Harmsen WS, De Andrade M, Locke GR 3rd, Petersen GM, Talley NJ. Irritable bowel syndrome aggregates strongly in families: a family-based case-control study. Neurogastroenterol Motil. 2008 Jul; 20(7):790-7. 1892684
    View PubMed
  139. Shah ND, Chitkara DK, Locke GR, Meek PD, Talley NJ. Ambulatory care for constipation in the United States, 1993-2004. Am J Gastroenterol. 2008 Jul; 103(7):1746-53. Epub 2008 Jun 28. 1894800
    View PubMed
  140. Talley NJ, Choung RS, Camilleri M, Dierkhising RA, Zinsmeister AR. Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia. Aliment Pharmacol Ther. 2008 Jun 1; 27(11):1122-31. Epub 2008 Mar 07. 1902517
    View PubMed
  141. Walker MM, Talley NJ. Functional gastrointestinal disorders and the potential role of eosinophils. Gastroenterol Clin North Am. 2008 Jun; 37(2):383-95, vi. 1909416
    View PubMed
  142. Talley NJ. Chronic unexplained diarrhea: what to do when the initial workup is negative? Rev Gastroenterol Disord. 2008 Summer; 8(3):178-85. 1906479
    View PubMed
  143. Choung RS, Talley NJ. Epidemiology and clinical presentation of stress-related peptic damage and chronic peptic ulcer. Curr Mol Med. 2008 Jun; 8(4):253-7. 1894830
    View PubMed
  144. Jiang X, Locke GR 3rd, Choung RS, Zinsmeister AR, Schleck CD, Talley NJ. Prevalence and risk factors for abdominal bloating and visible distention: a population-based study. Gut. 2008 Jun; 57(6):756-63. 1883258
    View PubMed
  145. Talley NJ, Tack J, Ptak T, Gupta R, Giguere M. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials. Gut. 2008 Jun; 57(6):740-6. Epub 2007 Oct 26. 1883260
    View PubMed
  146. Prasad GA, Talley NJ. Eosinophilic esophagitis in adults. Gastroenterol Clin North Am. 2008 Jun; 37(2):349-68, v-vi. 1892587
    View PubMed
  147. Talley NJ. Gut eosinophilia in food allergy and systemic and autoimmune diseases. Gastroenterol Clin North Am. 2008 Jun; 37(2):307-32, v. 1892588
    View PubMed
  148. Talley NJ. Eosinophilic and autoimmune gastrointestinal disease: new insights and new entities. Preface. Gastroenterol Clin North Am. 2008 Jun; 37(2):xi-xii. 1892589
    View PubMed
  149. Eslick GD, Talley NJ. Dysphagia: epidemiology, risk factors and impact on quality of life--a population-based study. Aliment Pharmacol Ther. 2008 May; 27(10):971-9. Epub 2008 Feb 28. 1904842
    View PubMed
  150. Stevens JE, Russo A, Maddox AF, Rayner CK, Phillips L, Talley NJ, Giguere M, Horowitz M, Jones KL. Effect of itopride on gastric emptying in longstanding diabetes mellitus. Neurogastroenterol Motil. 2008 May; 20(5):456-63. Epub 2008 Jan 07. 1904762
    View PubMed
  151. Tuteja AK, Talley NJ, Joos SK, Tolman KG, Hickam DH. Abdominal bloating in employed adults: prevalence, risk factors, and association with other bowel disorders. Am J Gastroenterol. 2008 May; 103(5):1241-8. Epub 2008 Apr 16. 1906550
    View PubMed
  152. Talley NJ. Functional gastrointestinal disorders as a public health problem. Neurogastroenterol Motil. 2008 May; 20 Suppl 1:121-9. 1892590
    View PubMed
  153. McNally MA, Locke GR, Zinsmeister AR, Schleck CD, Peterson J, Talley NJ. Biliary events and an increased risk of new onset irritable bowel syndrome: A population-based cohort study. Aliment Pharmacol Ther. 2008 Apr 13. [Epub ahead of print] 1909528
    View PubMed
  154. Haag S, Senf W, Hauser W, Tagay S, Grandt D, Heuft G, Gerken G, Talley NJ, Holtmann G. Impairment of health-related quality of life in functional dyspepsia and chronic liver disease: the influence of depression and anxiety. Aliment Pharmacol Ther. 2008 Apr 1; 27(7):561-71. Epub 2008 Jan 16. 1899066
    View PubMed
  155. Topazian M, Camilleri M, De La Mora-Levy J, Enders FB, Foxx-Orenstein AE, Levy MJ, Nehra V, Talley NJ. Endoscopic ultrasound-guided gastric botulinum toxin injections in obese subjects: a pilot study. Obes Surg. 2008 Apr; 18(4):401-7. Epub 2008 Feb 20. 1899017
    View PubMed
  156. Talley NJ. How to do and interpret a rectal examination in gastroenterology. Am J Gastroenterol. 2008 Apr; 103(4):820-2. 1883050
    View PubMed
  157. Talley NJ. Commentary: Controversies in NICE guidance on irritable bowel syndrome. BMJ. 2008 Mar 8; 336(7643):558-9. 1867781
    View PubMed
  158. Choung RS, Ferguson DD, Murray JA, Kammer PP, Dierkhising RA, Zinsmeister AR, Nurbhai S, Landau SB, Talley NJ. A novel partial 5HT3 agonist DDP733 after a standard refluxogenic meal reduces reflux events: a randomized, double-blind, placebo-controlled pharmacodynamic study. Aliment Pharmacol Ther. 2008 Mar 1; 27(5):404-11. Epub 2007 Dec 11. 1869930
    View PubMed
  159. Choung RS, Cremonini F, Thapa P, Zinsmeister AR, Talley NJ. The effect of short-term, low-dose tricyclic and tetracyclic antidepressant treatment on satiation, postnutrient load gastrointestinal symptoms and gastric emptying: a double-blind, randomized, placebo-controlled trial. Neurogastroenterol Motil. 2008 Mar; 20(3):220-7. Epub 2007 Nov 20. 1869926
    View PubMed
  160. Talley NJ, Fock KM, Moayyedi P. Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer. Am J Gastroenterol. 2008 Mar; 103(3):510-4. 1883225
    View PubMed
  161. Fock KM, Talley N, Moayyedi P, Hunt R, Azuma T, Sugano K, Xiao SD, Lam SK, Goh KL, Chiba T, Uemura N, Kim JG, Kim N, Ang TL, Mahachai V, Mitchell H, Rani AA, Liou JM, Vilaichone RK, Sollano J, Asia-Pacific Gastric Cancer Consensus Conference. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol. 2008 Mar; 23(3):351-65. 1899257
    View PubMed
  162. Moayyedi P, Burch N, Akhtar-Danesh N, Enaganti SK, Harrison R, Talley NJ, Jankowski J. Mortality rates in patients with Barrett's oesophagus. Aliment Pharmacol Ther. 2008 Feb 15; 27(4):316-20. Epub 2007 Dec 06. 1899251
    View PubMed
  163. Rajan E, Gostout CJ, Lurken MS, Talley NJ, Locke GR, Szarka LA, Levy MJ, Sumiyama K, de la Mora-Levy JG, Bakken TA, Stoltz GJ, Knipschield MA, Farrugia G. Evaluation of endoscopic approaches for deep gastric-muscle-wall biopsies: what works? Gastrointest Endosc. 2008 Feb; 67(2):297-303. Epub 2007 Oct 29. 1872104
    View PubMed
  164. Hammer J, Talley NJ. Value of different diagnostic criteria for the irritable bowel syndrome among men and women. J Clin Gastroenterol. 2008 Feb; 42(2):160-6. 1898812
    View PubMed
  165. Tuteja AK, Talley NJ, Gelman SS, Alder SC, Thompson C, Tolman K, Hale DC. Development of functional diarrhea, constipation, irritable bowel syndrome, and dyspepsia during and after traveling outside the USA. Dig Dis Sci. 2008 Jan; 53(1):271-6. Epub 2007 Jun 05. 1966415
    View PubMed
  166. Barton PM, Moayyedi P, Talley NJ, Vakil NB, Delaney BC. A second-order simulation model of the cost-effectiveness of managing dyspepsia in the United States. Med Decis Making. 2008 Jan-Feb; 28(1):44-55. Epub 2007 Dec 05. 1898901
    View PubMed
  167. Talley NJ. Lansoprazole was not effective in young dyspeptic patients without Helicobacter pylori. ACP J Club. 2008 Jan-Feb; 148(1):10. 1910973
    View PubMed
  168. Fock KM, Talley NJ, Fass R, Goh KL, Katelaris P, Hunt R, Hongo M, Ang TL, Holtmann G, Nandurkar S, Lin SR, Wong BC, Chan FK, Rani AA, Bak YT, Sollano J, Ho KY, Manatsathit S. Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol. 2008 Jan; 23(1):8-22. 1888456
    View PubMed
  169. Talley NJ, Locke GR 3rd, McNally M, Schleck CD, Zinsmeister AR, Melton LJ 3rd. Impact of gastroesophageal reflux on survival in the community. Am J Gastroenterol. 2008 Jan; 103(1):12-9. Epub 2007 Sep 26. 1867650
    View PubMed
  170. Talley NJ, Kellow JE, Boyce P, Tennant C, Huskic S, Jones M. Antidepressant therapy (imipramine and citalopram) for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial. Dig Dis Sci. 2008 Jan; 53(1):108-15. Epub 2007 May 15. 1872114
    View PubMed
  171. Talley NJ, Ruff K, Jiang X, Jung HK. The Rome III Classification of dyspepsia: will it help research? Dig Dis. 2008; 26(3):203-9. Epub 2008 May 06. 1888408
    View PubMed
  172. Bolling-Sternevald E, Aro P, Ronkainen J, Storskrubb T, Talley NJ, Junghard O, Agreus L. Do gastrointestinal symptoms fluctuate in the short-term perspective? The Kalixanda study. Dig Dis. 2008; 26(3):256-63. Epub 2008 May 07. 1931403
    View PubMed
  173. Agreus L, Talley NJ, Sheen A, Johansson SE, Jones MP, Svardsudd K. Predictors and non-predictors of symptom relief in dyspepsia consultations in primary care. Dig Dis. 2008; 26(3):248-55. Epub 2008 May 07. 1931404
    View PubMed
  174. Storskrubb T, Aro P, Ronkainen J, Sipponen P, Nyhlin H, Talley NJ, Engstrand L, Stolte M, Vieth M, Walker M, Agreus L. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study. Scand J Gastroenterol. 2008; 43(12):1448-55. 1957732
    View PubMed
  175. Sandborn WJ, Vakil N, Talley NJ, Guda NM, Freeman ML, Hawes RH, Rex DK, Hanauer SB, Katz PO. Best of DDW 2008: Highlights from the 2008 Digestive Disease Week, May 17-22, 2008, San Diego, CA. Reviews in Gastroenterological Disorders. 2008; 8(2):123-54. 1978686
    View PubMed
  176. Prasad GA, Talley NJ, Romero Y, Arora AS, Kryzer LA, Smyrk TC, Alexander JA. Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol. 2007 Dec; 102(12):2627-32. Epub 2007 Aug 31. 1861286
    View PubMed
  177. Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Cumulative incidence of chronic constipation: a population-based study 1988-2003. Aliment Pharmacol Ther. 2007 Dec; 26(11-12):1521-8. Epub 2007 Oct 05. 1858431
    View PubMed
  178. Chang JY, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Risk factors for chronic constipation and a possible role of analgesics. Neurogastroenterol Motil. 2007 Nov; 19(11):905-11. 1853376
    View PubMed
  179. Crane SJ, Talley NJ. Chronic gastrointestinal symptoms in the elderly. Clin Geriatr Med. 2007 Nov; 23(4):721-34, v. 1858502
    View PubMed
  180. Choung RS, Locke GR 3rd, Zinsmeister AR, Schleck CD, Talley NJ. Epidemiology of slow and fast colonic transit using a scale of stool form in a community. Aliment Pharmacol Ther. 2007 Oct 1; 26(7):1043-50. 1844616
    View PubMed
  181. Talley NJ, Li Z. Helicobacter pylori: testing and treatment. Expert Rev Gastroenterol Hepatol. 2007 Oct; 1(1):71-9. 1929786
    View PubMed
  182. Talley NJ. Introducing Expert Review of Gastroenterology and Hepatology. Expert Rev Gastroenterol Hepatol. 2007 Oct; 1(1):1-2. 1929787
    View PubMed
  183. Beebe TJ, Talley NJ, Camilleri M, Jenkins SM, Anderson KJ, Locke GR 3rd. The HIPAA authorization form and effects on survey response rates, nonresponse bias, and data quality: a randomized community study. Med Care. 2007 Oct; 45(10):959-65. 1846320
    View PubMed
  184. Talley NJ, Walker MM, Aro P, Ronkainen J, Storskrubb T, Hindley LA, Harmsen WS, Zinsmeister AR, Agreus L. Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study. Clin Gastroenterol Hepatol. 2007 Oct; 5(10):1175-83. Epub 2007 Aug 07. 1848985
    View PubMed
  185. Levy RL, Finch EA, Crowell MD, Talley NJ, Jeffery RW. Behavioral intervention for the treatment of obesity: strategies and effectiveness data. Am J Gastroenterol. 2007 Oct; 102(10):2314-21. Epub 2007 Jun 11. 1844539
    View PubMed
  186. Harrison R, Perry I, Haddadin W, McDonald S, Bryan R, Abrams K, Sampliner R, Talley NJ, Moayyedi P, Jankowski JA. Detection of Intestinal Metaplasia in Barrett's Esophagus. Am J Gastroenterol. 2007 Oct; 102(10):2353-4. 1844541
    View PubMed
  187. van Zanten SV, Flook N, Talley NJ, Vakil N, Lauritsen K, Bolling-Sternevald E, Persson T, Bjorck E, Svedberg LE, STARS II Study Group. One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks' treatment with esomeprazole: a randomized, placebo-controlled study. Aliment Pharmacol Ther. 2007 Sep 1; 26(5):665-72. 1844644
    View PubMed
  188. Talley NJ, Vakil N, Lauritsen K, van Zanten SV, Flook N, Bolling-Sternevald E, Persson T, Bjorck E, Lind T, STARS I Study Group. Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response? Aliment Pharmacol Ther. 2007 Sep 1; 26(5):673-82. 1844645
    View PubMed
  189. Talley NJ. Functional nausea and vomiting. Aust Fam Physician. 2007 Sep; 36(9):694-7. 1846474
    View PubMed
  190. Choung RS, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Do distinct dyspepsia subgroups exist in the community? A population-based study. Am J Gastroenterol. 2007 Sep; 102(9):1983-9. Epub 2007 Jun 20. 1841591
    View PubMed
  191. Halder SL, Locke GR 3rd, Schleck CD, Zinsmeister AR, Melton LJ 3rd, Talley NJ. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology. 2007 Sep; 133(3):799-807. Epub 2007 Jun 20. 1841450
    View PubMed
  192. Chitkara DK, Talley NJ, Locke GR 3rd, Weaver AL, Katusic SK, De Schepper H, Rucker MJ. Medical presentation of constipation from childhood to early adulthood: a population-based cohort study. Clin Gastroenterol Hepatol. 2007 Sep; 5(9):1059-64. Epub 2007 Jul 13. 1844597
    View PubMed
  193. Jung HK, Halder S, McNally M, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population. Aliment Pharmacol Ther. 2007 Aug 1; 26(3):453-61. 1836979
    View PubMed
  194. Halder SL, Talley NJ. Functional Dyspepsia: A New Rome III Paradigm. Curr Treat Options Gastroenterol. 2007 Aug; 10(4):259-72. 1910969
    View PubMed
  195. Crane SJ, Locke GR 3rd, Harmsen WS, Diehl NN, Zinsmeister AR, Melton LJ 3rd, Romero Y, Talley NJ. Subsite-specific risk factors for esophageal and gastric adenocarcinoma. Am J Gastroenterol. 2007 Aug; 102(8):1596-602. Epub 2007 Apr 24. 1839119
    View PubMed
  196. Lembo A, Zaman M, Jones M, Talley NJ. Influence of genetics on irritable bowel syndrome, gastro-oesophageal reflux and dyspepsia: a twin study. Aliment Pharmacol Ther. 2007 Jun 1; 25(11):1343-50. 1827974
    View PubMed
  197. Saito YA, Locke GR 3rd, Zimmerman JM, Holtmann G, Slusser JP, de Andrade M, Petersen GM, Talley NJ. A genetic association study of 5-HTT LPR and GNbeta3 C825T polymorphisms with irritable bowel syndrome. Neurogastroenterol Motil. 2007 Jun; 19(6):465-70. 1824681
    View PubMed
  198. Harrison R, Perry I, Haddadin W, McDonald S, Bryan R, Abrams K, Sampliner R, Talley NJ, Moayyedi P, Jankowski JA. Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Am J Gastroenterol. 2007 Jun; 102(6):1154-61. Epub 2007 Apr 13. 1828111
    View PubMed
  199. Cash BD, Chang E, Talley NJ, Wald A. Fresh perspectives in chronic constipation and other functional bowel disorders. Rev Gastroenterol Disord. 2007 Summer; 7(3):116-33. 1844494
    View PubMed
  200. Camilleri M, Mangel AW, Fehnel SE, Drossman DA, Mayer EA, Talley NJ. Primary endpoints for irritable bowel syndrome trials: a review of performance of endpoints. Clin Gastroenterol Hepatol. 2007 May; 5(5):534-40. Epub 2007 Apr 11. 1820544
    View PubMed
  201. Ronkainen J, Talley NJ, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Vieth M, Stolte M, Walker MM, Agreus L. Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut. 2007 May; 56(5):615-20. 1820419
    View PubMed
  202. Haag S, Senf W, Tagay S, Langkafel M, Braun-Lang U, Pietsch A, Heuft G, Talley NJ, Holtmann G. Is there a benefit from intensified medical and psychological interventions in patients with functional dyspepsia not responding to conventional therapy? Aliment Pharmacol Ther. 2007 Apr 15; 25(8):973-86. 1817584
    View PubMed
  203. Hawkey CJ, Jones RH, Yeomans ND, Scheiman JM, Talley NJ, Goldstein JL, Ahlbom H, Naesdal J. Efficacy of esomeprazole for resolution of symptoms of heartburn and acid regurgitation in continuous users of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther. 2007 Apr 1; 25(7):813-21. 1815224
    View PubMed
  204. McNally MA, Talley NJ. Current treatments in functional dyspepsia. Curr Treat Options Gastroenterol. 2007 Mar; 10(2):157-68. 1910970
    View PubMed
  205. Choung RS, Talley NJ, Peterson J, Camilleri M, Burton D, Harmsen WS, Zinsmeister AR. A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers. Neurogastroenterol Motil. 2007 Mar; 19(3):180-7. 1807111
    View PubMed
  206. Liebregts T, Adam B, Bredack C, Roth A, Heinzel S, Lester S, Downie-Doyle S, Smith E, Drew P, Talley NJ, Holtmann G. Immune activation in patients with irritable bowel syndrome. Gastroenterology. 2007 Mar; 132(3):913-20. 1817443
    View PubMed
  207. Talley NJ. Functional Gastrointestinal Disorders in 2007 and Rome III: something new, something borrowed, something objective. Rev Gastroenterol Disord. 2007 Spring; 7(2):97-105. 1830748
    View PubMed
  208. Crane SJ, Locke GR 3rd, Harmsen WS, Diehl NN, Zinsmeister AR, Melton LJ 3rd, Romero Y, Talley NJ. The changing incidence of oesophageal and gastric adenocarcinoma by anatomic sub-site. Aliment Pharmacol Ther. 2007 Feb 15; 25(4):447-53. 1846535
    View PubMed
  209. Richter JE, Talley NJ. American Journal of Gastroenterology 2006: The Best Clinical GI Journal in the World. Am J Gastroenterol. 2007 Feb; 102(2):229-31. 1910967
    View PubMed
  210. Chitkara DK, Talley NJ, Weaver AL, Katusic SK, De Schepper H, Rucker MJ, Locke GR 3rd. Incidence of presentation of common functional gastrointestinal disorders in children from birth to 5 years: a cohort study. Clin Gastroenterol Hepatol. 2007 Feb; 5(2):186-91. 1810499
    View PubMed
  211. Liebregts T, Adam B, Bertel A, Lackner C, Neumann J, Talley NJ, Gerken G, Holtmann G. Psychological stress and the severity of post-inflammatory visceral hyperalgesia. Eur J Pain. 2007 Feb; 11(2):216-22. 1794620
    View PubMed
  212. Bueno L, De Ponti F, Fried M, Kullak-Ublick GA, Kwiatek MA, Pohl D, Quigley EMM, Tack J, Talley NJ. Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity. Neurogastroenterol Motil. 2007 Jan; 19(Suppl 1):89-119. 1802236
    View PubMed
  213. Talley NJ. How to manage the difficult-to-treat dyspeptic patient. Nat Clin Pract Gastroenterol Hepatol. 2007 Jan; 4(1):35-42. 1799828
    View PubMed
  214. Talley NJ. Irritable bowel syndrome: rational therapy. Consultant. 2007 Jan; 47(1):81-3, 87-8, 89-90. 1848911
    View PubMed
  215. Hawkey CJ, Talley NJ, Scheiman JM, Jones RH, Langstrom G, Naesdal J, Yeomans ND, NASA/SPACE author group. Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: the NASA2 and SPACE2 studies. Arthritis Res Ther. 2007; 9(1):R17. 1820631
    View PubMed
  216. Grudell AB, Alexander JA, Enders FB, Pacifico R, Fredericksen M, Wise JL, Locke GR 3rd, Arora A, Zais T, Talley NJ, Romero Y. Validation of the Mayo Dysphagia Questionnaire. Dis Esophagus. 2007; 20(3):202-5. 1822580
    View PubMed
  217. Choung RS, Talley NJ. Food allergy and intolerance in IBS. J Gastroenterol Hepatol. 2007; 2:756-60. 1910968
  218. Hanauer SB, Sandborn WJ, Vakil N, Katz PO, Talley NJ, Rex DK, Hawes RH, Guda NM, Freeman ML. Best of DDW 2007. Rev Gastroenterol Disor. 2007; 7(3):134-66. 1911507
  219. Talley NJ. The role of endoscopy in dyspepsia. ASGE Clinical Update. 2007; 15(1):1-4. 1975842
    View PubMed
  220. Kalantar JS, Talley NJ. Towards a diagnosis of functional dyspepsia. Med Today. 2007; 8(12):45-50. 1975645
    View PubMed
  221. Crowell MD, Decker GA, Levy R, Jeffrey R, Talley NJ. Gut-brain neuropeptides in the regulation of ingestive behaviors and obesity. Am J Gastroenterol. 2006 Dec; 101(12):2848-56; quiz 2914. Epub 2006 Oct 06. 1794537
    View PubMed
  222. Talley NJ. Irritable bowel syndrome. Intern Med J. 2006 Nov; 36(11):724-8. 1787085
    View PubMed
  223. Cremonini F, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Relationship between upper gastrointestinal symptoms and changes in body weight in a population-based cohort. Neurogastroenterol Motil. 2006 Nov; 18(11):987-94. 1789256
    View PubMed
  224. Halder SL, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Influence of alcohol consumption on IBS and dyspepsia. Neurogastroenterol Motil. 2006 Nov; 18(11):1001-8. 1789257
    View PubMed
  225. Chitkara DK, Van Tilburg M, Whitehead WE, Talley NJ. Teaching diaphragmatic breathing for rumination syndrome. Am J Gastroenterol. 2006 Nov; 101(11):2449-52. 1791367
    View PubMed
  226. Koloski NA, Boyce PM, Talley NJ. Somatization an independent psychosocial risk factor for irritable bowel syndrome but not dyspepsia: a population-based study. Eur J Gastroenterol Hepatol. 2006 Oct; 18(10):1101-9. 1804828
    View PubMed
  227. Talley NJ, Camilleri M, Burton D, Thomforde G, Koch K, Rucker MJ, Peterson J, Zinsmeister AR, Earnest DL. Double-blind, randomized, placebo-controlled study to evaluate the effects of tegaserod on gastric motor, sensory and myoelectric function in healthy volunteers. Aliment Pharmacol Ther. 2006 Sep 1; 24(5):859-67. 1778043
    View PubMed
  228. Vakil N, Moayyedi P, Fennerty MB, Talley NJ. Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis. Gastroenterology. 2006 Aug; 131(2):390-401; quiz 659-60. 1778016
    View PubMed
  229. Storskrubb T, Aro P, Ronkainen J, Wreiber K, Nyhlin H, Bolling-Sternevald E, Talley NJ, Engstrand L, Agreus L. Antimicrobial susceptibility of Helicobacter pylori strains in a random adult Swedish population. Helicobacter. 2006 Aug; 11(4):224-30. 1782350
    View PubMed
  230. Talley NJ, Armstrong D, Junghard O, Wiklund I. Predictors of treatment response in patients with non-erosive reflux disease. Aliment Pharmacol Ther. 2006 Jul 15; 24(2):371-6. 1769937
    View PubMed
  231. Hammer J, Talley NJ. Disturbed bowel habits in patients with non-ulcer dyspepsia. Aliment Pharmacol Ther. 2006 Jul 15; 24(2):405-10. 1769938
    View PubMed
  232. Vakil N, Talley NJ, Stolte M, Sundin M, Junghard O, Bolling-Sternevald E. Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal reflux disease in Western patients with non-ulcer dyspepsia. Aliment Pharmacol Ther. 2006 Jul 1; 24(1):55-63. 1770036
    View PubMed
  233. Chitkara DK, Bredenoord AJ, Talley NJ, Whitehead WE. Aerophagia and rumination: recognition and therapy. Curr Treat Options Gastroenterol. 2006 Jul; 9(4):305-13. 1911588
    View PubMed
  234. Talley NJ, Locke GR 3rd, Lahr BD, Zinsmeister AR, Tougas G, Ligozio G, Rojavin MA, Tack J. Functional dyspepsia, delayed gastric emptying, and impaired quality of life. Gut. 2006 Jul; 55(7):933-9. Epub 2005 Dec 01. 1765698
    View PubMed
  235. Talley NJ. Overlapping abdominal symptoms: why do GERD and IBS often coexist? Drugs Today (Barc) 2006 Jul; 42 Suppl B:3-8. 1815063
    View PubMed
  236. Moayyedi P, Talley NJ. Gastro-oesophageal reflux disease. Lancet. 2006 Jun 24; 367(9528):2086-100. 1769894
    View PubMed
  237. Ronkainen J, Aro P, Storskrubb T, Lind T, Bolling-Sternevald E, Junghard O, Talley NJ, Agreus L. Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population--the Kalixanda study. Aliment Pharmacol Ther. 2006 Jun 15; 23(12):1725-33. 1765337
    View PubMed
  238. Choung RS, Locke GR 3rd, Zinsmeister AR, Melton LJ 3rd, Talley NJ. Alternating bowel pattern: what do people mean? Aliment Pharmacol Ther. 2006 Jun 15; 23(12):1749-55. 1765338
    View PubMed
  239. Aro P, Storskrubb T, Ronkainen J, Bolling-Sternevald E, Engstrand L, Vieth M, Stolte M, Talley NJ, Agreus L. Peptic ulcer disease in a general adult population: the Kalixanda study: a random population-based study. Am J Epidemiol. 2006 Jun 1; 163(11):1025-34. Epub 2006 Mar 22. 1765336
    View PubMed
  240. Howell SC, Quine S, Talley NJ. Low social class is linked to upper gastrointestinal symptoms in an Australian sample of urban adults. Scand J Gastroenterol. 2006 Jun; 41(6):657-66. 1762917
    View PubMed
  241. Saito YA, Talley NJ, de Andrade M, Petersen GM. Case-control genetic association studies in gastrointestinal disease: review and recommendations. Am J Gastroenterol. 2006 Jun; 101(6):1379-89. 1765211
    View PubMed
  242. Andresen V, Camilleri M, Kim HJ, Stephens DA, Carlson PJ, Talley NJ, Saito YA, Urrutia R, Zinsmeister AR. Is there an association between GNbeta3-C825T genotype and lower functional gastrointestinal disorders? Gastroenterology. 2006 Jun; 130(7):1985-94. 1765702
    View PubMed
  243. Hanauer SB, Sandborn WJ, Vakil N, Katz PO, Talley NJ, Rex DK, Hawes RH, Guda NM, Freeman ML, Keeffe EB, Balart LA. Best of DDW 2006. Rev Gastroenterol Disord. 2006 Summer; 6(3):153-89. 1911586
    View PubMed
  244. Talley NJ, Locke GR, Lahr BD, Zinsmeister AR, Cohard-Radice M, D'Elia TV, Tack J, Earnest DL. Predictors of the placebo response in functional dyspepsia. Aliment Pharmacol Ther. 2006 Apr 1; 23(7):923-36. 1754297
    View PubMed
  245. Design of Treatment Trials Committee, Irvine EJ, Whitehead WE, Chey WD, Matsueda K, Shaw M, Talley NJ, Veldhuyzen van Zanten SJ. Design of treatment trials for functional gastrointestinal disorders. Gastroenterology. 2006 Apr; 130(5):1538-51. 1968873
    View PubMed
  246. Scheiman JM, Yeomans ND, Talley NJ, Vakil N, Chan FK, Tulassay Z, Rainoldi JL, Szczepanski L, Ung KA, Kleczkowski D, Ahlbom H, Naesdal J, Hawkey C. Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am J Gastroenterol. 2006 Apr; 101(4):701-10. Epub 2006 Feb 22. 1968876
    View PubMed
  247. Tally NJ. Chronic constipation and irritable bowel syndrome: epidemiology, presentation, and diagnosis... includes discussion. Advanced Studies in Medicine. 2006 Apr; 6(4A):S225-31, S251-3. 1772793
    View PubMed
  248. Talley NJ. How effective is fluoxetine for the treatment of pain and constipation-predominant irritable bowel syndrome? Nat Clin Pract Gastroenterol Hepatol. 2006 Apr; 3(4):196-7. 1758049
    View PubMed
  249. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, Stanghellini V. Functional gastroduodenal disorders. Gastroenterology. 2006 Apr; 130(5):1466-79. 1762803
    View PubMed
  250. Malfertheiner P, Fass R, Quigley EM, Modlin IM, Malagelada JR, Moss SF, Holtmann G, Goh KL, Katelaris P, Stanghellini V, Talley NJ, Tytgat GN, Wright NA. Review article: from gastrin to gastro-oesophageal reflux disease--a century of acid suppression. Aliment Pharmacol Ther. 2006 Mar 15; 23(6):683-90. 1752279
    View PubMed
  251. Talley NJ. A unifying hypothesis for the functional gastrointestinal disorders: really multiple diseases or one irritable gut? Rev Gastroenterol Disord. 2006 Spring; 6(2):72-8. 1769945
    View PubMed
  252. Holtmann G, Talley NJ, Liebregts T, Adam B, Parow C. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med. 2006 Feb 23; 354(8):832-40. 1750459
    View PubMed
  253. Talley NJ, Richter J. Nobel Prize in Medicine awarded to a Gastroenterologist in 2005. Am J Gastroenterol. 2006 Feb; 101(2):211. 1752205
    View PubMed
  254. Boyce PM, Talley NJ, Burke C, Koloski NA. Epidemiology of the functional gastrointestinal disorders diagnosed according to Rome II criteria: an Australian population-based study. Intern Med J. 2006 Jan; 36(1):28-36. 1910961
    View PubMed
  255. Fajardo NR, Wise JL, Locke GR 3rd, Murray JA, Talley NJ. Esophageal perforation after placement of wireless Bravo pH probe. Gastrointest Endosc. 2006 Jan; 63(1):184-5. 1744169
    View PubMed
  256. Hancox RJ, Poulton R, Taylor DR, Greene JM, McLachlan CR, Cowan JO, Flannery EM, Herbison GP, Sears MR, Talley NJ. Associations between respiratory symptoms, lung function and gastro-oesophageal reflux symptoms in a population-based birth cohort. Respir Res. 2006; 7:142. Epub 2006 Dec 05. 1799558
    View PubMed
  257. Stolte M, Muller H, Talley NJ, O'morain C, Bolling-Sternevald E, Sundin M, Eriksson S, Blum A. In patients with Helicobacter pylori gastritis and functional dyspepsia, a biopsy from the incisura angularis provides useful diagnostic information. Pathol Res Pract. 2006; 202(6):405-13. Epub 2006 May 05. 1769876
    View PubMed
  258. Moayyedi P, Talley NJ, Fennerty MB, Vakil N. Can the clinical history distinguish between organic and functional dyspepsia? JAMA. 2006; 295:1566-76. 1910963
  259. Talley NA, Talley NJ. Hepatitis C: diagnosis and management issues. Australian Defense Force Health. 2006; 7:22-8. 1910965
  260. Rex DK, Talley NJ, Katz PO, Hanauer SB, Sandborn WJ. Report from the ACG: Highlights of the 71st Annual Scientific Meeting of the American College of Gastroenterology, October 20-25, Las Vegas, NV. Reviews in Gastroenterological Disorders. 2006; 6(4):227-42. 1971817
    View PubMed
  261. Fajardo NR, Cremonini F, Talley NJ. Management of constipation in patients with cancer. Am J Cancer. 2006; 5(5):319-30. 1971829
    View PubMed
  262. Rex DK, Hanauer SB, Sandborn WJ, Katz PO, Talley NJ. Report from the ACG. Highlights of the 70th Annual Scientific Meeting of the American College of Gastroenterology October 28-November 2, 2005, Honolulu, HI. Reviews in Gastroenterological Disorders. 2006; 6(1):35-47. 1972106
    View PubMed
  263. Choung RS, Talley NJ. Food allergy and intolerance in IBS. Gastroenterol. Hepatol. 2006; 2(10):756-60. 1971911
    View PubMed
  264. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Vieth M, Stolte M, Talley NJ, Agreus L. Prevalence of Barrett's esophagus in the general population: An endoscopic study. Gastroenterology. 2005 Dec; 129(6):1825-31. 1743606
    View PubMed
  265. Saito YA, Locke GR, Weaver AL, Zinsmeister AR, Talley NJ. Diet and functional gastrointestinal disorders: A population-based case-control study. Am J Gastroenterol. 2005 Dec; 100(12):2743-8. 1737094
    View PubMed
  266. Talley N. Stop your intestines from rebelling. Bottom Line/Health. 2005 Dec; 19(12):5-6. 1748203
    View PubMed
  267. Talley NJ. Differentiating functional constipation from constipation-predominant irritable bowel syndrome: management implications. Rev Gastroenterol Disord. 2005 Winter; 5(1):1-9. 1703766
    View PubMed
  268. Yeomans ND, Lanas AI, Talley NJ, Thomson ABR, Daneshjoo R, Eriksson B, Appelman-Eszczuk S, Langstrom G, Naesdal J, Serrano P, Singh M, Skelly MM, Hawkey CJ. Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. Aliment Pharmacol Ther. 2005 Nov 1; 22(9):795-801. 1732149
    View PubMed
  269. Chitkara DK, Bredenoord AJ, Rucker MJ, Talley NJ. Aerophagia in adults: a comparison with functional dyspepsia. Aliment Pharmacol Ther2005 Nov 1; 22(9):855-8. 1732150
    View PubMed
  270. Wise JL, Locke GR, Zinsmeister AR, Talley NJ. Risk factors for non-cardiac chest pain in the community. Aliment Pharmacol Ther 2005 Nov; 22(10):1023-31. 1732280
    View PubMed
  271. Talley NJ, Vakil NB, Moayyedi P. American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology. 2005 Nov; 129(5):1756-80. 1743670
    View PubMed
  272. Saito YA, Petersen GM, Locke GR 3rd, Talley NJ. The genetics of irritable bowel syndrome. Clin Gastroenterol Hepatol. 2005 Nov; 3(11):1057-65. 1739996
    View PubMed
  273. Talley NJ. Review: prompt endoscopy is not a cost-effective strategy for initial management of dyspepsia. ACP J Club. 2005 Nov-Dec; 143(3):76. 1748207
    View PubMed
  274. Aro P, Ronkainen J, Talley NJ, Storskrubb T, Bolling-Sternevald E, Agreus L. Body mass index and chronic unexplained gastrointestinal symptoms: an adult endoscopic population based study. Gut. 2005 Oct; 54(10):1377-83. 1731851
    View PubMed
  275. Talley NJ, Vakil N. Guidelines for the management of dyspepsia. Am J Gastroenterol. 2005 Oct; 100(10):2324-37. 1731872
    View PubMed
  276. Eslick GD, Coulshed DS, Talley NJ. Diagnosis and treatment of noncardiac chest pain. Nat Clin Pract Gastroenterol Hepatol. 2005 Oct; 2(10):463-72. 1731984
    View PubMed
  277. Howell S, Poulton R, Talley NJ. The natural history of childhood abdominal pain and its association with adult irritable bowel syndrome: Birth-cohort study. Am J Gastroenterol. 2005 Sep; 100(9):2071-8. 1731873
    View PubMed
  278. Ahlawat SK, Richard Locke G, Weaver AL, Farmer SA, Yawn BP, Talley NJ. Dyspepsia consulters and patterns of management: a population-based study. Aliment Pharmacol Ther. 2005 Aug 1; 22(3):251-9. 1992968
    View PubMed
  279. Fajardo NR, Cremonini F, Talley NJ. Frontiers in functional dyspepsia. Curr Gastroenterol Rep. 2005 Aug; 7(4):289-96. 1740241
    View PubMed
  280. Chitkara DK, Rawat DJ, Talley NJ. The epidemiology of childhood recurrent abdominal pain in western countries: A systematic review. Am J Gastroenterol. 2005 Aug; 100(8):1868-75. 1729871
    View PubMed
  281. Chitkara DK, Bredenood AJ, Wang M, Rucker MJ, Talley NJ. Aerophagia in children: characterization of a functional gastrointestinal disorder. Neurogastroenterol Motil. 2005 Aug; 17(4):518-22. 1729832
    View PubMed
  282. Burton DD, Kim HJ, Camilleri M, Stephens DA, Mullan BP, O'Connor MK, Talley NJ. Relationship of gastric emptying and volume changes after a solid meal in humans. Am J Physiol Gastrointest Liver Physiol. 2005 Aug; 289(2):G261-6. 1721408
    View PubMed
  283. Nandurkar S, Locke GR, Murray JA, Melton LJ, Zinsmeister AR, Dierkhising R, Talley NJ. Rates of endoscopy and endoscopic findings among people with frequent symptoms of gastroesophageal reflux in the community. Am J Gastroenterol. 2005 Jul; 100(7):1459-65. 1720606
    View PubMed
  284. Fawcett JP, Barbezat GO, Poulton R, Milne BJ, Xia HH, Talley NJ. Helicobacter pylori serology in a birth cohort of New Zealanders from age 11 to 26. World J Gastroenterol. 2005 Jun 7; 11(21):3273-6. 1910959
    View PubMed
  285. Cremonini F, Wise J, Moayyedi P, Talley NJ. Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: A metaanalysis. Am J Gastroenterol. 2005 Jun; 100(6):1226-32. 1720403
    View PubMed
  286. Cremonini F, Talley NJ. Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors. Gastroenterol Clin North Am. 2005 Jun; 34(2):189-204. 1718783
    View PubMed
  287. Camilleri M, Dubois D, Coulie B, Jones M, Kahrilas PJ, Rentz AM, Sonnenberg A, Stanghellini V, Stewart WF, Tack J, Talley NJ, Whitehead W, Revicki DA. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol. 2005 Jun; 3(6):543-52. 1729891
    View PubMed
  288. Hawkey C, Talley NJ, Yeomans ND, Jones R, Sung JJY, Langstrom G, Naesdal J, Scheiman JM. Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitors. Am J Gastroenterol. 2005 May; 100(5):1028-36. 1708158
    View PubMed
  289. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Graffner H, Vieth M, Stolte M, Engstrand L, Talley NJ, Agreus L. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: A Kalixanda study report. Scand J Gastroenterol. 2005 Feb; 40(3):275-85. 1701628
    View PubMed
  290. Storskrubb T, Aro P, Ronkainen J, Vieth M, Stolte M, Wreiber K, Engstrand L, Nyhlin H, Bolling-Sternevald E, Talley NJ, Agreus L. A negative Helicobacter pylori serology test is more reliable for exclusion of premalignant gastric conditions than a negative test for current H-pylori infection: A report on histology and H-pylori detection in the general adult population. Scand J Gastroenterol. 2005 Feb; 40(3):302-11. 1701629
    View PubMed
  291. Cuddihy MT, Locke GR, Wahner-Roedler D, Dierkhising R, Zinsmeister AR, Long KH, Talley NJ. Dyspepsia management in primary care: a management trial. Int J Clin Pract. 2005 Feb; 59(2):194-201. 1701663
    View PubMed
  292. Kamm MA, Muller-Lissner S, Talley NJ, Tack J, Boeckxstaens G, Minushkin ON, Kalinin A, Dzieniszewski J, Haeck P, Fordham F, Hugot-Cournez S, Nault B. Tegaserod for the treatment of chronic constipation: A randomized, double-blind, placebo-controlled multinational study. Am J Gastroenterol. 2005 Feb; 100(2):362-72. 1694229
    View PubMed
  293. Talley NJ, Wiklund I. Patient reported outcomes in gastroesophageal reflux disease: An overview of available measures. Qual Life Res. 2005 Feb; 14(1):21-33. 1694407
    View PubMed
  294. Locke GR, Zinsmeister AR, Fett SL, Melton LJ, Talley NJ. Overlap of gastrointestional symptom complexes in a US community. Neurogastroenterology & Motility. 2005 Feb; 17(1):29-34. 1694056
    View PubMed
  295. Cremonini F, Talley NJ. Treatments targeting putative mechanisms in irritable bowel syndrome. Nat Clin Pract Gastroenterol Hepatol. 2005 Feb; 2(2):82-8. 1720318
    View PubMed
  296. Koloski NA, Boyce PM, Talley NJ. Is health care seeking for irritable bowel syndrome and functional dyspepsia a socially learned response to illness? Dig Dis Sci. 2005 Jan; 50(1):153-62. 1694200
    View PubMed
  297. Tuteja AK, Talley NJ, Joos SK, Woehl JV, Hickam DH. Is constipation associated with decreased physical activity in normally active subjects? Am J Gastroenterol. 2005 Jan; 100(1):124-9. 1677913
    View PubMed
  298. Talley NJ. Environmental versus genetic risk factors for irritable bowel syndrome: clinical and therapeutic implications. Rev Gastroenterol Disord. 2005; 5(2):82-8. 1718741
    View PubMed
  299. Brandt LJ, Schoenfeld P, Prather CM, Quigley EMM, Schiller LR, Talley NJ. Evidence-based position statement on the management of chronic constipation in North America. Am J Gastroenterol. 2005; 100(1 Suppl S):1-4. 1720401
    View PubMed
  300. Brandt LJ, Prather CM, Quigley EMM, Schiller LR, Schoenfeld P, Talley NJ. Systematic review on the management of chronic constipation in North America. Am J Gastroenterol. 2005; 100(1 Suppl S):S5-S22. 1720402
    View PubMed
  301. Koloski NA, Talley NJ, Boyce PM. A history of abuse in community subjects with irritable bowel syndrome and functional dyspepsia: The role of other psychosocial variables. Digestion. 2005; 72(2-3):86-96. 1732115
    View PubMed
  302. Talley NJ, Camilleri M, Chitkara DK, Bouras E, Locke GR, Burton D, Rucker MJ, Thapa P, Zinsmeister AR. Effects of desipramine and escitalopram on postprandial symptoms induced by the nutrient drink test in healthy volunteers: A randomized, double-blind, placebo-controlled study. Digestion. 2005; 72(2-3):97-103. 1732116
    View PubMed
  303. Halder SLS, Talley NJ. Treatment of functional dyspepsia. Curr Treat Options Gastroenterol. 2005; 8(4):325-36. 1743768
    View PubMed
  304. Talley NJ. Epidemiology, severity, and impact of irritable bowel syndrome. Pract Gastroenterol. 2005; 29(4 Suppl):4-12. 1743647
    View PubMed
  305. Vege SS, Locke GR, Weaver AL, Farmer SA, Melton LJ, Talley NJ. Functional gastrointestinal disorders among people with sleep disturbances: A population-based study. Mayo Clin Proc. 2004 Dec; 79(12):1501-6. 1674488
    View PubMed
  306. Aro P, Ronkainen J, Storskrubb T, Bolling-Sternevald E, Svardsudd K, Talley NJ, Junghard O, Johansson SE, Wiklund I, Agreus L. Validation of the translation and cross-cultural adaptation into Finnish of the Abdominal Symptom Questionnaire, the Hospital Anxiety and Depression Scale and the Complaint Score Questionnaire. Scand J Gastroenterol. 2004 Dec; 39(12):1201-8. 1674011
    View PubMed
  307. Aro P, Ronkainen J, Storskrubb T, Bolling-Sternevald E, Carlsson R, Johansson SE, Vieth M, Stolte M, Engstrand L, Talley NJ, Agreus L. Valid symptom reporting at upper endoscopy in a random sample of the Swedish adult general population: the Kalixanda study. Scand J Gastroenterol. 2004 Dec; 39(12):1280-8. 1674012
    View PubMed
  308. Talley NJ. Management of chronic constipation. Reviews in Gastroenterological Disorders. 2004 Win; 4(1):18-24. 1647187
    View PubMed
  309. de la Loge C, Trudeau E, Marquis P, Kahrilas P, Stanghellini V, Talley NJ, Tack J, Revicki DA, Rentz AM, Dubois D. Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI-QOL. Qual Life Res. 2004 Dec; 13(10):1751-62. 1910952
    View PubMed
  310. Rentz AM, Kahrilas P, Stanghellini V, Tack J, Talley NJ, de la Loge C, Trudeau E, Dubois D, Revicki DA. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res. 2004 Dec; 13(10):1737-49. 1910957
    View PubMed
  311. Cremonini F, Talley NJ. Review article: the overlap between functional dyspepsia and irritable bowel syndrome a tale of one or two disorders. Aliment Pharmacol Ther. 2004 Nov; 20(Suppl 7):40-9. 1677784
    View PubMed
  312. Moayyedi P, Delaney BC, Vakil N, Forman D, Talley NJ. The efficacy of proton pump inhibitors in nonulcer dyspepsia: A systematic review and economic analysis. Gastroenterology. 2004 Nov; 127(5):1329-37. 1674053
    View PubMed
  313. Eslick GD, Talley NJ. Non-cardiac chest pain: predictors of health care seeking, the types of health care professional consulted, work absenteeism and interruption of daily activities. Alimentary Pharmacology & Therapeutics. 2004 Oct 15; 20(8):909-15. 1669399
    View PubMed
  314. Haag S, Talley NJ, Holtmann G. Symptom patterns in functional dyspepsia and irritable bowel syndrome: relationship to disturbances in gastric emptying and response to a nutrient challenge in consulters and non-consulters. Gut. 2004 Oct; 53(10):1445-51. 1665834
    View PubMed
  315. Talley NJ, Vakil N, Delaney B, Marshall B, Bytzer P, Engstrand L, de Boer W, Jones R, Malfertheiner P, Agreus L. Management issues in dyspepsia: Current consensus and controversies. Scand J Gastroenterol. 2004 Oct; 39(10):913-8. 1665772
    View PubMed
  316. Crowell MD, Lacy BE, Schettler VA, Dineen TN, Olden KW, Talley NJ. Subtypes of anal incontinence associated with bowel dysfunction: Clinical, physiologic, and psychosocial characterization. Dis Colon Rectum. 2004 Oct; 47(10):1627-35. 1669341
    View PubMed
  317. Talley NJ. Practical examples: trials and conclusions - an interactive segment. Alimentary Pharmacology & Therapeutics. 2004 Oct; 20(Suppl 5):9-13. 1665915
    View PubMed
  318. Talley NJ. Gastro-oesophageal reflux disease - how wide is its span? Alimentary Pharmacology & Therapeutics. 2004 Oct; 20(Suppl 5):27-37. 1665916
    View PubMed
  319. Dent J, Talley NJ. Clinical strategies - interactive case discussions. Alimentary Pharmacology & Therapeutics. 2004 Oct; 20(Suppl 5):97-104. 1665917
    View PubMed
  320. Rohrbock RBK, Hammer J, Vogelsang H, Talley NJ, Hammer HF. Acupuncture has a placebo effect on rectal perception but not on distensibility and spatial summation: A study in health and IBS. Am J Gastroenterol. 2004 Oct; 99(10):1990-7. 1669396
    View PubMed
  321. Cremonini F, Talley NJ. Diagnostic and therapeutic strategies in the irritable bowel syndrome. Minerva Med. 2004 Oct; 95(5):427-41. 1674569
    View PubMed
  322. Nandurkar S, Locke GR, Fett S, Zinsmeister AR, Cameron AJ, Talley NJ. Relationship between body mass index, diet, exercise and gastro-oesophageal reflux symptoms in a community. Aliment Pharmacol Ther. 2004 Sep 1; 20(5):497-505. 1663596
    View PubMed
  323. Delgado-Aros S, Locke GR, Camilleri M, Talley NJ, Fett S, Zinsmeister AR, Melton LJ. Obesity is associated with increased risk of gastrointestinal symptoms: A population-based study. Am J Gastroenterol. 2004 Sep; 99(9):1801-6. 1663591
    View PubMed
  324. Talley NJ, Howell S, Poulton R. Obesity and chronic gastrointestinal tract symptoms in young adults: A birth cohort study. Am J Gastroenterol. 2004 Sep; 99(9):1807-14. 1663592
    View PubMed
  325. Friedrich WN, Whiteside SP, Talley NJ. Noncoercive sexual contact with similarly aged individuals: what is the impact? Journal of Interpersonal Violence. 2004 Sep; 19(9):1075-84. 1665856
    View PubMed
  326. Armstrong D, Talley NJ, Lauritsen K, Moum B, Lind T, Tunturi-Hihnala H, Venables T, Green J, Bigard MA, Mossner J, Junghard O. The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole. Alimentary Pharmacology & Therapeutics. 2004 Aug 15; 20(4):413-21. 1660780
    View PubMed
  327. Cremonini F, Delgado-Aros S, Talley NJ. Functional dyspepsia: drugs for new (and old) therapeutic targets. Best Pract Res Clin Gastroenterol. 2004 Aug; 18(4):717-33. 1663741
    View PubMed
  328. Talley NJ, Quan C, Jones MP, Horowitz M. Association of upper and lower gastrointestinal tract symptoms with body mass index in an Australian cohort. Neurogastroenterol Motil. 2004 Aug; 16(4):413-9. 1660708
    View PubMed
  329. Howell S, Talley NJ, Quine S, Poulton R. The irritable bowel syndrome has origins in the childhood socioeconomic environment. Am J Gastroenterol. 2004 Aug; 99(8):1572-8. 1662273
    View PubMed
  330. Talley NJ. What the physician needs to know for correct management of gastro-oesophageal reflux disease and dyspepsia. Alimentary Pharmacology & Therapeutics. 2004 Jul; 20(Suppl 2):23-30. 1662420
    View PubMed
  331. Locke GR, Yawn BP, Wollan PC, Melton LJ, Lydick E, Talley NJ. Incidence of a clinical diagnosis of the irritable bowel syndrome in a United States population. Aliment Pharmacol Ther. 2004 May 1; 19(9):1025-31. 1644292
    View PubMed
  332. Hammer J, Eslick GD, Howell SC, Altiparmak E, Talley NJ. Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia. Gut. 2004 May 1; 53(5):666-72. 1642973
    View PubMed
  333. Revicki DA, Rentz AM, Dubois D, Kahrilas P, Stanghellini V, Talley NJ, Tack J. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res. 2004 May; 13(4):833-44. 1910958
    View PubMed
  334. Dent J, Armstrong D, Delaney B, Moayyedi P, Talley NJ, Vakil N. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut. 2004 May; 53(Suppl 4):1-24. 1644330
    View PubMed
  335. Holtmann G, Kutscher SU, Haag S, Langkafel M, Heuft G, Neufang-Hueber J, Goebell H, Senf W, Talley NJ. Clinical presentation and personality factors are predictors of the response to treatment in patients with functional dyspepsia - A randomized, double-blind placebo-controlled crossover study. Dig Dis Sci. 2004 Apr; 49(4):672-9. 1644336
    View PubMed
  336. Fock KM, Talley N, Hunt R, Fass R, Nandurkar S, Lam SK, Goh KL, Sollano J. Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol. 2004 Apr; 19(4):357-67. 1639604
    View PubMed
  337. Holtmann G, Siffert W, Haag S, Mueller N, Langkafel M, Senf W, Zotz R, Talley NJ. G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functioncal) dyspepsia. Gastroenterology. 2004 Apr; 126(4):971-9. 1642978
    View PubMed
  338. Camilleri M, Talley NJ. Pathophysiology as a basis for understanding symptom complexes and therapeutic targets. Neurogastroenterol Motil. 2004 Apr; 16(2):135-42. 1643016
    View PubMed
  339. Locke GR, Murray JA, Zinsmeister AR, Melton LJ, Talley NJ. Celiac disease serology in irritable bowel syndrome and dyspepsia: A population-based case-control study. Mayo Clin Proc. 2004 Apr; 79(4):476-82. 1641261
    View PubMed
  340. El-Serag HB, Talley NJ. Systematic review: The prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther. 2004 Mar 15; 19(6):643-54. 1639680
    View PubMed
  341. Locke GR, Weaver AL, Melton LJ, Talley NJ. Psychosocial factors are linked to functional gastrointestinal disorders: A population based nested case-control study. Am J Gastroenterol. 2004 Feb; 99(2):350-7. 1520503
    View PubMed
  342. Halder SLS, Locke GR, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ. Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case-control study. Aliment Pharmacol Ther. 2004 Jan 15; 19(2):233-42. 1517970
    View PubMed
  343. Eslick GD, Howell SC, Hammer J, Talley NJ. Empirically derived symptom sub-groups correspond poorly with diagnostic criteria for functional dyspepsia and irritable bowel syndrome. A factor and cluster analysis of a patient sample. Aliment Pharmacol Ther. 2004 Jan 1; 19(1):133-40. 1431681
    View PubMed
  344. Crowell MD, Shetzline MA, Moses PL, Mawe GM, Talley NJ. Enterochromaffin cells and 5-HT signaling in the pathophysiology of disorders of gastrointestinal function. Curr Opin Investig Drugs. 2004 Jan; 5(1):55-60. 1647233
    View PubMed
  345. Talley NJ. Irritable bowel syndrome remains a difficult condition to manage. Drug Benefit Trends. 2004; 16(6):313-22. 1653013
    View PubMed
  346. Talley NJ. Definitions, epidemiology, and impact of chronic constipation. Reviews in Gastroenterological Disorders. 2004; 4(Suppl 2):S3-S10. 1653040
    View PubMed
  347. Delgado-Aros S, Cremonini F, Talley NJ. Treatment of functional dyspepsia. Curr Treat Options Gastroenterol. 2004; 7(2):121-31. 1653747
    View PubMed
  348. Feinle-Bisset C, Vozzo R, Horowitz M, Talley NJ. Diet, food intake and disturbed physiology in the pathogenesis of symptoms in functional dyspepsia. American Journal of Gastroenterology. 2004; 99:17081. 1667703
    View PubMed
  349. Talley NJ. Functional gastrointestinal disorders. DDW Reviews in Gastroenterological Disorders 2004 Review; 4:144-146. 1667726
    View PubMed
  350. Mearin F, Roset M, Badia X, Balboa A, Baro E, Ponce J, Diaz-Rubio M, Caldwell E, Cucala M, Fueyo A, Talley NJ. Splitting Irritable Bowel Syndrome: From Original Rome to Rome II Criteria. American Journal of Gastroenterology. 2004; 99:122-130. 1667593
    View PubMed
  351. Peura DA, Kovacs TO, Metz DC, Siepman N, Pilmer BL, Talley NJ. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials. American Journal of Medicine. 2004; 116:740-8. 1667594
    View PubMed
  352. De la Loge C, Trudeau E, Marquis P, Revicki D, Rentz AM, Stanghellini V, Talley NJ, Kahrilas P, Tack J, Dubois D. Responsiveness and interpretation of a quality of life questionnaire specific to upper-gastrointestinal disorders. Clinical Gastroenterology and Hepatology. 2004; 2:778-786. 1667596
    View PubMed
  353. Revicki DA, Rentz AM, Tack J, Stanghellini V, Talley NJ, Kahrilas P, de la Loge C, Trudeau E, Dubois D. Responsiveness and interpretation of the patient assessment of Gastrointestinal Symptom Severity Index (PAGI-SYM). Clinical Gastroenterology and Hepatology. 2004; 2:769-77. 1667598
    View PubMed
  354. Xia HHX, Wong BCY, Zhang GS, Yang Y, Wyatt JM, Adams S, Cheung K, Lam SK, Talley NJ. Antralization of gastric incisura is topographically associated with increased gastric epithelial apoptosis and proliferation, but not with CagA seropositivity. Journal of Gastroenterology & Hepatology. 2004; 19:1257-63. 1667603
    View PubMed
  355. Kalantar JS, Locke GR, Zinsmeister AR, Beighley CM, Talley NJ. Familial aggregation of irritable bowel syndrome: a prospective study. Gut. 2003 Dec 1; 52(12):1703-7. 1425143
    View PubMed
  356. Saito YA, Talley NJ, Melton LJ, Fett S, Zinsmeister AR, Locke GR. The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates. Neurogastroenterol Motil. 2003 Dec; 15(6):687-94. 1429070
    View PubMed
  357. Locke GR, Zinsmeister AR, Talley NJ. Can symptoms predict endoscopic findings in GERD? Gastrointest Endosc. 2003 Nov; 58(5):661-70. 1422428
    View PubMed
  358. Talley NJ, Dennis EH, Schettler-Duncan VA, Lacy BE, Olden KW, Crowell MD. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol. 2003 Nov; 98(11):2454-9. 1429042
    View PubMed
  359. Boyce PM, Talley NJ, Balaam B, Koloski NA, Truman G. A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome. Am J Gastroenterol. 2003 Oct; 98(10):2209-18. 1910950
    View PubMed
  360. Talley NJ. Evaluation of drug treatment in irritable bowel syndrome. Br J Clin Pharmacol. 2003 Oct; 56(4):362-9. 1415053
    View PubMed
  361. Talley NJ. Dyspepsia. Gastroenterology. 2003 Oct; 125(4):1219-26. 1417041
    View PubMed
  362. El-Serag HB, Talley NJ. Systematic review: health-related quality of life in functional dyspepsia. Alimentary Pharmacology & Therapeutics. 2003 Aug 15; 18(4):387-93. 1413624
    View PubMed
  363. Kalantar JS, Locke GR, Talley NJ, Zinsmeister AR, Fett SL, Melton LJ. Is irritable bowel syndrome more likely to be persistent in those with relatives who suffer from gastrointestinal symptoms? A population-based study at three time points. Aliment Pharmacol Ther. 2003 Jun 1; 17(11):1389-97. 1355858
    View PubMed
  364. Westbrook JI, Talley NJ. Diagnostic investigation rates and use of prescription and non-prescription medications amongst dyspeptics: a population-based study of 2300 Australians. Aliment Pharmacol Ther. 2003 May 1; 17(9):1171-8. 1910948
    View PubMed
  365. Talley NJ, Jones M, Nuyts G, Dubois D. Risk factors for chronic constipation based on a general practice sample. Am J Gastroenterol. 2003 May; 98(5):1107-11. 1396796
    View PubMed
  366. Xia HHX, Talley NJ, Blum AL, O'Morain CA, Stolte M, Bolling-Sternevald E, Mitchell HM. Clinical and pathological implications of IgG antibody responses to Helicobacter pylori and its virulence factors in non-ulcer dyspepsia. Alimentary Pharmacology & Therapeutics. 2003 Apr 1; 17(7):935-43. 1429426
    View PubMed
  367. Talley NJ. Pharmacologic therapy for the irritable bowel syndrome. Am J Gastroenterol. 2003 Apr; 98(4):750-8. 1346792
    View PubMed
  368. Koloski NA, Talley NJ, Boyce PM. Does psychological distress modulate functional gastrointestinal symptoms and health care seeking? A prospective, community Cohort study. Am J Gastroenterol. 2003 Apr; 98(4):789-97. 1910947
    View PubMed
  369. Hammer J, Howell S, Bytzer P, Horowitz M, Talley NJ. Symptom clustering in subjects with and without diabetes mellitus: a population-based study of 15000 Australian adults. Am J Gastroenterol. 2003 Feb; 98(2):391-8. 1293876
    View PubMed
  370. Talley NJ. Diabetic gastropathy and prokinetics. Am J Gastroenterol. 2003 Feb; 98(2):264-71. 1293898
    View PubMed
  371. Weltman M, Talley NJ. An approach to recurrent, non-identifiable GI bleeding. New Ethicals Journal. 2003; New Ethicals Journal. 2003:57-63. 1911491
  372. Cremonini F, Talley NJ. Commentary – The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome by Creed F, Fernandes L, Guthrie E, et al. Br Med J. 2003; 8:160. 1911496
  373. Talley NJ. Omeprazole was effective in the short term for uninvestigated dyspepsia ACP J Club. 2003; 138:1-3. 1911605
  374. Talley NJ. When to conduct testing in patients with suspected irritable bowel syndrome. Reviews in Gastroenterological Disorders. 2003; 3 Suppl 3:S18-24. 1726718
    View PubMed
  375. Müller-Lissner S, Koch G, Talley NJ, Drossman D, Rueegg P, Dunger-Baldauf C, Lefkowitz M. Subject’s global assess (SGA) of relief: an appropriate method to assess the impact of treatment on irritable bowel syndrome-related symptoms in clinical trials. Journal of Clinical Epidemiology. 2003; 56:310-16. 1667584
    View PubMed
  376. Eslick GD, Jones MP, Talley NJ. Non-cardiac chest pain: prevalence, risk factors, impact and consulting – a population-based study. Alimentary Pharmacology and Therapeutics. 2003; 17:1115-1124. 1667585
    View PubMed
  377. Quan C, Talley NJ, Cross S, Jones M, Hammer J, Giles N, Horowitz M. Development and validation of the diabetes bowel symptom questionnaire. Alimentary Pharmacology and Therapeutics. 2003; 17:1179-1187. 1667587
    View PubMed
  378. Revicki DA, Rentz AM, Dubois D, Kahrilas P, Stanghellini V, Talley NJ, Tack J. Development and validation of a patient assessed gastroparesis symptom severity measure: the gastroparesis cardinal symptom index (GCSI). Alimentary Pharmacology and Therapeutics. 2003; 18:141-50. 1667588
    View PubMed
  379. Bolling-Sternevald E, Lauritsen K, Talley NJ, Junghard O, Glise H. Is it possible to predict treatment response to a proton pump inhibitor in functional dyspepsia? Alimentary Pharmacology and Therapeutics. 2003; 18:117-124. 1667589
    View PubMed
  380. Howell S, Poulton R, Caspi A, Talley NJ. Relationship between abdominal pain subgroups in the community and psychiatric diagnosis and personality. A birth cohort study Journal of Psychosomatic Research. 2003; 55:179-87. 1667590
  381. Mearin F, Balboa A, Badia X, Baro E, Caldwell E, Cucala M, Diaz-Rubio M, Fueyo A, Ponce J, Roset M, Talley NJ. Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype. European Journal of Gastorenterology and Hepatology. 2003; 15:165-72. 1667591
  382. Talley NJ. Functional Disorders. Target the brain to get the gain? Reviews in Gastrointestinal Disorders. 2003; 3:182-4. 1667680
  383. Talley NJ. Best of DDW 2003. New insights on treatment of irritable bowel syndrome and functional dyspepsia Reviews in Gastroenterological Disorders. 2003; 3:172-5. 1667681
  384. Talley NJ. Update on the Role of Drug Therapy in Non-Ulcer Dyspepsia. Reviews in Gastroenterological Disorders. 2003; 3:25-30. 1667682
    View PubMed
  385. Wiklund I, Talley NJ. Update on health-related quality of life in patients with gastroesophageal reflux disease (GERD). Expert Rev Pharmacoeconomics & Outcomes Research. 2003; 3:341-50. 1667683
  386. Dent J, Talley NJ. Overview: initial and long-term management of gastro-oesophageal reflux disease. Alimentary Pharmacology and Therapeutics. 2003; 1(17 Suppl):53-7. 1667684
  387. Weltman MD, Talley NJ. Chronic hepatitis C infection: a review and update on treatment strategies. ADF Health. 2003; 4:27-33. 1667693
  388. Moayyedi P, Deeks J, Talley NJ, Delaney B, Forman D. An update of the Cochrane systematic review of Helicobactor pylori eradication therapy in non-ulcer dyspepsia. Resolving the discrepancy between systematic reviews. American Journal of Gastroenterology. 2003; 98(12):2621-2626. 1667701
    View PubMed
  389. Talley NJ. Helicobacter pylori management: how to improve the therapeutic confusion in practice. Canadian Journal of Gastroenterology. 2003; B:21B-24B. 1667702
  390. Howe SC, Quine S, Talley NJ. Ethics review and use of reminder letters in postal surveys: are current practices comprising an evidence-based approach? Med J Aust. 2003; 178:43. 1346843
    View PubMed
  391. Koloski NA, Talley NJ, Huskic SS, Boyce PM. Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia. Alimentary Pharmacology and Therapeutics. 2003; 17:841-51. 1293910
    View PubMed
  392. Talley NJ, Howell S, Jones MP, Horowitz M. Predictors of turnover of lower gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol. 2002 Dec; 97(12):3087-94. 1293900
    View PubMed
  393. Quan C, Talley NJ. Management of peptic ulcer disease not related to Helicobacter pylori or NSAIDs. Am J Gastroenterol. 2002 Dec; 97(12):2950-61. 1293901
    View PubMed
  394. Katelaris PH, Forbes GM, Talley NJ, Crotty B. A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE Study. Gastroenterology. 2002 Dec; 123(6):1763-9. 1293880
    View PubMed
  395. Xia HH, Zhang GS, Talley NJ, Wong BC, Yang Y, Henwood C, Wyatt JM, Adams S, Cheung K, Xia B, Zhu YQ, Lam SK. Topographic association of gastric epithelial expression of Ki-67, Bax, and Bcl-2 with antralization in the gastric incisura, body, and fundus. Am J Gastroenterol. 2002 Dec; 97(12):3023-31. 1910944
    View PubMed
  396. Holtmann G, Gschossmann J, Buenger L, Gerken G, Talley NJ. Do changes in visceral sensory function determine the development of dyspepsia during treatment with aspirin? Gastroenterology. 2002 Nov; 123(5):1451-8. 1293877
    View PubMed
  397. Talley NJ, Moore MG, Sprogis A, Katelaris P. Randomised controlled trial of pantoprazole versus ranitidine for the treatment of uninvestigated heartburn in primary care. Med J Aust. 2002 Oct 21; 177(8):423-7. 1293887
    View PubMed
  398. Jones MP, Talley NJ, Nuyts G, Dubois D. Lack of objective evidence of efficacy of laxatives in chronic constipation. Dig Dis Sci. 2002 Oct; 47(10):2222-30. 1293885
    View PubMed
  399. Holtmann G, Gschossmann J, Mayr P, Talley NJ. A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia. Aliment Pharmacol Ther. 2002 Sep; 16(9):1641-8. 1293899
    View PubMed
  400. Eslick GD, Yan P, Xia HH, Murray H, Spurrett B, Talley NJ. Foetal intrauterine growth restrictions with Helicobacter pylori infection. Aliment Pharmacol Ther. 2002 Sep; 16(9):1677-82. 1293890
    View PubMed
  401. Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking in the functional GI disorders: a population-based study. Am J Gastroenterol. 2002 Sep; 97(9):2290-9. 1293881
    View PubMed
  402. Talley NJ, Venables TL, Green JR, Armstrong D, O'Kane KP, Giaffer M, Bardhan KD, Carlsson RG, Chen S, Hasselgren GS. Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months. Eur J Gastroenterol Hepatol. 2002 Aug; 14(8):857-63. 1293884
    View PubMed
  403. Westbrook JI, Talley NJ. Empiric clustering of dyspepsia into symptom subgroups: a population-based study. Scand J Gastroenterol. 2002 Aug; 37(8):917-23. 1293889
    View PubMed
  404. Veldhuyzen van Zanten SJ, Talley NJ, Blum AL, Bolling-Sternevald E, Sundin M, Junghard O. Combined analysis of the ORCHID and OCAY studies: does eradication of Helicobacter pylori lead to sustained improvement in functional dyspepsia symptoms? Gut. 2002 May; 50(Suppl 4):iv26-30; discussion iv31-2. 1293871
    View PubMed
  405. Westbrook JI, Talley NJ, Westbrook MT. Gender differences in the symptoms and physical and mental well-being of dyspeptics: a population based study. Qual Life Res. 2002 May; 11(3):283-91. 1293874
    View PubMed
  406. Talley NJ. Dyspepsia: management guidelines for the millennium. Gut. 2002 May; 50(Suppl 4):iv72-8; discussion iv79. 1294381
    View PubMed
  407. Talley NJ, Lauritsen K. The potential role of acid suppression in functional dyspepsia: the BOND, OPERA, PILOT, and ENCORE studies. Gut. 2002 May; 50(Suppl 4):iv36-41. 1294382
    View PubMed
  408. Jones KL, Wishart JM, Berry M, Russo A, Xia HH, Talley NJ, Horowitz M. Helicobacter pylori infection is not associated with delayed gastric emptying or upper gastrointestinal symptoms in diabetes mellitus. Dig Dis Sci. 2002 Apr; 47(4):704-9. 1293873
    View PubMed
  409. Bytzer P, Talley NJ, Hammer J, Young LJ, Jones MP, Horowitz M. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol. 2002 Mar; 97(3):604-11. 1293869
    View PubMed
  410. Kalantar JS, Howell S, Talley NJ. Prevalence of faecal incontinence and associated risk factors: an underdiagnosed problem in the Australian community? Med J Aust. 2002 Jan 21; 176(2):54-7. 1293847
    View PubMed
  411. Friedrich WN, Whiteside SP, Talley NJ. A research perspective on the compliant child victim. APSAC Advisor. 2002; 14(2):19-20. 1396668
    View PubMed
  412. Weltmann MD, Talley NJ. An approach to recurrent non-identifiable GI bleeding. Curr Ther. 2002; 43:27-35. 1346666
    View PubMed
  413. Coulshed DS, Eslick GD, Talley NJ. Non-cardiac chest pain: patients need diagnoses? Br Med J. 2002; 324:915. 1346704
    View PubMed
  414. Badia X, Mearin F, Balboa A, Baro E, Caldwell E, Cucala M, Diaz-Rubio M, Fueyo A, Ponce J, Roset M, Talley NJ. Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria. Pharmacoeconomics. 2002; 20(11):749-58. 1293882
    View PubMed
  415. Talley NJ, Spiller R. Irritable bowel syndrome: a little understood organic bowel disease? Lancet. 2002; 360:555-64. 1294385
    View PubMed
  416. Talley NJ. Dyspepsia management in the millennium: the death of test and treat? Gastroenterology. 2002; 122:1521-5. 1294386
    View PubMed
  417. Eslick GD, Coulshed DS, Talley NJ. The burden of illness of non-cardiac chest pain. Aliment Pharmacol Ther. 2002; 16:1217-23. 1294387
    View PubMed
  418. Talley NJ. Dyspepsia: how to manage and how to treat? Aliment Pharmacol Ther. 2002; 16(Suppl 4):95-104. 1294388
    View PubMed
  419. Talley NJ, Quan C. Helicobacter pylori and non-ulcer dyspepsia. Aliment Pharmacol Ther. 2002; 16(Suppl 1):58-65. 1294390
    View PubMed
  420. Waldum HL, Brenna E, Alberti H, Jones R, Dent J, Kahrilas P, Talley NJ. Gastro-oesphageal reflux disease in general practice. Br Med J. 2002; 324:485. 1294392
  421. Axon A, Talley NJ, Veldhuyzen Van Zanten SJ. pH-Hp: implications for dyspepsia management. Gut. 2002; 50(Suppl 4):iv1. 1294394
    View PubMed
  422. Bennett G, Talley NJ. Irritable bowel syndrome in the elderly. Best Practice of Clinical Gastroenterology. 2002; 16:63-76. 1294396
  423. Talley NJ, Abeygunasekera S. Bile reflux and Barrett's oesophagus: innocent bystander or sinister companion? Digestive and Liver Disease. 2002; 34:246-8. 1294397
    View PubMed
  424. Abeygunasekera S, Talley NJ. Management of dysepsia. Comprehensive Therapy. 2002; 28:182-9. 1294399
    View PubMed
  425. Xia HH, Yu Wong BC, Talley NJ, Lam SK. Alternative and rescue treatment regimens for Helicobacter pylori eradication. Expert Opin Pharmacother. 2002; 3:1301-11. 1294401
    View PubMed
  426. Jones R, Dent J, Kahrilas P, Talley NJ. Management of gastro-oesphageal reflux disease in general practice. Br Med J. 2002; 322:344-7. 1911487
  427. Talley NJ. Serotoninergic neuroenteric modulators. Lancet. 2001 Dec 15; 358(9298):2061-8. 1294383
    View PubMed
  428. Xia HH, Phung N, Altiparmak E, Berry A, Matheson M, Talley NJ. Reduction of peptic ulcer disease and Helicobacter pylori infection but increase of reflux esophagitis in Western Sydney between 1990 and 1998. Dig Dis Sci. 2001 Dec; 46(12):2716-23. 1293848
    View PubMed
  429. Mearin F, Badia X, Balboa A, Baro E, Caldwell E, Cucala M, Diaz-Rubio M, Fueyo A, Ponce J, Roset M, Talley NJ. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol. 2001 Nov; 36(11):1155-61. 1293864
    View PubMed
  430. Agreus L, Svardsudd K, Talley NJ, Jones MP, Tibblin G. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol. 2001 Oct; 96(10):2905-14. 1293866
    View PubMed
  431. Levy RL, Jones KR, Whitehead WE, Feld SI, Talley NJ, Corey LA. Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology. 2001 Oct; 121(4):799-804. 1293859
    View PubMed
  432. Talley NJ, Riff DS, Schwartz H, Marcuard SP. Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection. Aliment Pharmacol Ther. 2001 Oct; 15(10):1603-11. 1293856
    View PubMed
  433. Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med. 2001 Sep 10; 161(16):1989-96. 1293858
    View PubMed
  434. Talley NJ, Verlinden M, Geenen DJ, Hogan RB, Riff D, McCallum RW, Mack RJ. Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial. Gut. 2001 Sep; 49(3):395-401. 1293855
    View PubMed
  435. Talley NJ. Irritable bowel syndrome. Best Practice of Medicine. 2001 Sep. 1294373
  436. Bytzer P, Howell S, Leemon M, Young LJ, Jones MP, Talley NJ. Low socioeconomic class is a risk factor for upper and lower gastrointestinal symptoms: a population based study in 15 000 Australian adults. Gut. 2001 Jul; 49(1):66-72. 1293849
    View PubMed
  437. Holtmann G, Gschossmann J, Holtmann M, Talley NJ. H. pylori and functional dyspepsia: increased serum antibodies as an independent risk factor? Dig Dis Sci. 2001 Jul; 46(7):1550-7. 1293854
    View PubMed
  438. Talley NJ. Drug therapy options for patients with irritable bowel syndrome. Am J Manag Care. 2001 Jul; 7(8 Suppl):S261-7. 1294369
    View PubMed
  439. Talley NJ, Fullerton S, Junghard O, Wiklund I. Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. Am J Gastroenterol. 2001 Jul; 96(7):1998-2004. 1293845
    View PubMed
  440. Shaw MJ, Beebe TJ, Adlis SA, Talley NJ. Reliability and validity of the digestive health status instrument in samples of community, primary care, and gastroenterology patients. Aliment Pharmacol Ther. 2001 Jul; 15(7):981-7. 1293846
    View PubMed
  441. Bytzer P, Talley NJ. Current indications for acid suppressants in dyspepsia. Best Pract Res Clin Gastroenterol. 2001 Jun; 15(3):385-400. 1294367
    View PubMed
  442. Talley NJ, Thitiphuree S. Lump or split dyspepsia? A continuing controversy. Curr Gastroenterol Rep. 2001 Jun; 3(3):175-6. 1294360
    View PubMed
  443. Bytzer P, Talley NJ. Dyspepsia. Ann Intern Med. 2001 May 1; 134(9 Pt 2):815-22. 1294371
    View PubMed
  444. Talley NJ, Verlinden M, Jones M. Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia? Am J Gastroenterol. 2001 May; 96(5):1422-8. 1293834
    View PubMed
  445. Koloski NA, Talley NJ, Boyce PM. Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical review of the literature on symptom and psychosocial factors. Am J Gastroenterol. 2001 May; 96(5):1340-9. 1293821
    View PubMed
  446. Talley SJ, Bytzer P, Hammer J, Young L, Jones M, Horowitz M. Psychological distress is linked to gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol. 2001 Apr; 96(4):1033-8. 1293825
    View PubMed
  447. McManis PG, Newall D, Talley NJ. Abdominal wall muscle activity in irritable bowel syndrome with bloating. Am J Gastroenterol. 2001 Apr; 96(4):1139-42. 1293829
    View PubMed
  448. Talley NJ, Van Zanten SV, Saez LR, Dukes G, Perschy T, Heath M, Kleoudis C, Mangel AW. A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia. Aliment Pharmacol Ther. 2001 Apr; 15(4):525-37. 1293842
    View PubMed
  449. Talley NJ, Howell S, Poulton R. The irritable bowel syndrome and psychiatric disorders in the community: is there a link? Am J Gastroenterol. 2001 Apr; 96(4):1072-9. 1293833
    View PubMed
  450. Xia HH, Talley NJ, Kam EP, Young LJ, Hammer J, Horowitz M. Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol. 2001 Apr; 96(4):1039-46. 1293844
    View PubMed
  451. Shaw MJ, Fendrick AM, Kane RL, Adlis SA, Talley NJ. Self-reported effectiveness and physician consultation rate in users of over-the-counter histamine-2 receptor antagonists. Am J Gastroenterol. 2001 Mar; 96(3):673-6. 1293843
    View PubMed
  452. Talley NJ, Lauritsen K, Tunturi-Hihnala H, Lind T, Moum B, Bang C, Schulz T, Omland TM, Delle M, Junghard O. Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months. Aliment Pharmacol Ther. 2001 Mar; 15(3):347-54. 1293837
    View PubMed
  453. Veldhuyzen van Zanten SJ, Jones MJ, Verlinden M, Talley NJ. Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis. Am J Gastroenterol. 2001 Mar; 96(3):689-96. 1293827
    View PubMed
  454. Xia HH, Yu Wong BC, Talley NJ, Lam SK. Helicobacter pylori infection--current treatment practice. Expert Opin Pharmacother. 2001 Feb; 2(2):253-66. 1979820
    View PubMed
  455. Talley NJ, Verlinden M, Jones M. Quality of life in functional dyspepsia: responsiveness of the Nepean Dyspepsia Index and development of a new 10-item short form. Aliment Pharmacol Ther. 2001 Feb; 15(2):207-16. 1293824
    View PubMed
  456. Xia HH, Talley NJ. Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol. 2001 Jan; 96(1):16-26. 1294357
    View PubMed
  457. Bytzer P, Talley NJ, Jones MP, Horowitz M. Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus. Aliment Pharmacol Ther. 2001 Jan; 15(1):137-42. 1293832
    View PubMed
  458. Shaw MJ, Talley NJ, Beebe TJ, Rockwood T, Carlsson R, Adlis S, Fendrick AM, Jones R, Dent J, Bytzer P. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol. 2001 Jan; 96(1):52-7. 1293826
    View PubMed
  459. Talley NJ, Young L, Bytzer P, Hammer J, Leemon M, Jones M, Horowitz M. Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastroenterol. 2001 Jan; 96(1):71-6. 1293820
    View PubMed
  460. Boyce P, Hickey A, Gilchrist J, Talley NJ. The development of a brief personality scale to measure vulnerability to postnatal depression. Archive of Women's Mental Health. 2001; 3:147-53. 1293840
  461. Bensoussan A, Chang SW, Menzies RG, Talley NJ. Application of the general health status questionnaire SF36 to patients with gastrointestinal dysfunction: initial validation and validation as a measure of change. Aust N Z J Public Health. 2001; 25(1):71-7. 1293841
    View PubMed
  462. Dent J, Jones R, Kahrilas PJ, Talley NJ. Management of gastro-oesophageal reflux disease in general practice. Br Med J. 2001; 322:344-47. 1294362
  463. Talley NJ. Commentary on "Community screening for Helicobacter pylori does not improve quality of life.". Evidence Based Healthcare. 2001; 5:7. 1294363
  464. Talley NJ. Therapeutic options in nonulcer dyspepsia. J Clin Gastroenterol. 2001; 96:673-6. 1294364
  465. Talley NJ. Metholdogical issues in irritable bowel syndrome clinical trials: practical relevance for the clinician. Practical Gastroenterology. 2001; 8:16-23. 1294374
  466. Talley NJ. Dealing with patients' concerns and expectations. Eur J Gastroenterol Hepatol. 2001; 13(Suppl 3):S5-6. 1294376
  467. Talley NJ. Should oesophagitis be healed? Eur J Gastroenterol Hepatol. 2001; 13(Suppl 3):S36-7. 1294377
  468. Talley NJ. Efficacies of different proton pump inhibitors in reflux disease. Eur J Gastroenterol Hepatol. 2001; 13(Suppl 3):S55-6. 1294378
  469. Talley NJ. When and why should empirically treated patients have endoscopy? Eur J Gastroenterol Hepatol. 2001; 13(Suppl 3):S75-6. 1294379
  470. Talley NJ, Phung N, Kalantar JS. ABC of the upper gastrointestinal tract: indigestion: when is it functional? Br Med J. 2001; 323:1294-7. 1294391
  471. Koloski NA, Talley NJ, Boyce PM, Morris-Yates AD. The effect of questionnaire length and lottery ticket incentive on the response rate in mail surveys. Psychology & Health. 2001; 16:67-75. 1667579
  472. Westbrook JI, McIntosh J, Talley NJ. Factors associated with consulting medical or non-medical practitioners for dyspepsia: an Australian population-based study. Aliment Pharmacol Ther. 2000 Dec; 14(12):1581-8. 1293836
    View PubMed
  473. Talley NJ, Verlinden M, Snape W, Beker JA, Ducrotte P, Dettmer A, Brinkhoff H, Eaker E, Ohning G, Miner PB, Mathias JR, Fumagalli I, Staessen D, Mack RJ. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther. 2000 Dec; 14(12):1653-61. 1293818
    View PubMed
  474. Xia HH, Phung N, Kalantar JS, Talley NJ. Demographic and endoscopic characteristics of patients with Helicobacter pylori positive and negative peptic ulcer disease. Med J Aust. 2000 Nov 20; 173(10):515-9. 1293830
    View PubMed
  475. Hammer J, Talley NJ. Nonulcer dyspepsia. Curr Opin Gastroenterol. 2000 Nov; 16(6):503-7. 1294358
    View PubMed
  476. Nandurkar S, Talley NJ. Epidemiology and natural history of reflux disease. Baillieres Best Pract Res Clin Gastroenterol. 2000 Oct; 14(5):743-57. 1294384
    View PubMed
  477. Saito YA, Locke GR, Talley NJ, Zinsmeister AR, Fett SL, Melton LJ 3rd. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol. 2000 Oct; 95(10):2816-24. 139480
    View PubMed
  478. Locke GR 3rd, Zinsmeister AR, Talley NJ, Fett SL, Melton LJ 3rd. Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc. 2000 Sep; 75(9):907-12. 137268
    View PubMed
  479. Neri M, Laterza F, Howell S, Di Gioacchino M, Festi D, Ballone E, Cuccurullo F, Talley NJ. Symptoms discriminate irritable bowel syndrome from organic gastrointestinal diseases and food allergy. Eur J Gastroenterol Hepatol. 2000 Sep; 12(9):981-8. 1293822
    View PubMed
  480. Holtmann G, Gschossmann J, Neufang-Huber J, Gerken G, Talley NJ. Differences in gastric mechanosensory function after repeated ramp distensions in non-consulters with dyspepsia and healthy controls. Gut. 2000 Sep; 47(3):332-6. 1293828
    View PubMed
  481. Hu WH, Martin CJ, Talley NJ. Intraesophageal acid perfusion sensitizes the esophagus to mechanical distension: a Barostat study. Am J Gastroenterol. 2000 Sep; 95(9):2189-94. 1293817
    View PubMed
  482. Locke GR 3rd, Talley NJ, Nelson DK, Haruma K, Weaver AL, Zinsmeister AR, Melton LJ 3rd. Helicobacter pylori and dyspepsia: a population-based study of the organism and host. Am J Gastroenterol. 2000 Aug; 95(8):1906-13. 137125
    View PubMed
  483. Talley NJ, Holtmann G, Agreus L, Jones M. Gastrointestinal symptoms and subjects cluster into distinct upper and lower groupings in the community: a four nations study. Am J Gastroenterol. 2000 Jun; 95(6):1439-47. 1293813
    View PubMed
  484. Haque M, Wyeth JW, Stace NH, Talley NJ, Green R. Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: a population-based study. N Z Med J. 2000 May 26; 113(1110):178-81. 1293823
    View PubMed
  485. Xia HH, Kalantar JS, Mitchell HM, Talley NJ. Can helicobacter pylori serology still be applied as a surrogate marker to identify peptic ulcer disease in dyspepsia? Aliment Pharmacol Ther. 2000 May; 14(5):615-24. 1293811
    View PubMed
  486. Carpenter HA, Talley NJ. The importance of clinicopathological correlation in the diagnosis of inflammatory conditions of the colon: histological patterns with clinical implications. Am J Gastroenterol. 2000 Apr; 95(4):878-96. 1013172
    View PubMed
  487. Nandurkar S, Talley NJ, Martin CJ, Ng T, Adams S. Esophageal histology does not provide additional useful information over clinical assessment in identifying reflux patients presenting for esophagogastroduodenoscopy. Dig Dis Sci. 2000 Feb; 45(2):217-24. 1293803
    View PubMed
  488. Agreus L, Talley NJ, Svardsudd K, Tibblin G, Jones MP. Identifying dyspepsia and irritable bowel syndrome: the value of pain or discomfort and bowel habit descriptors. Scand J Gastroenterol. 2000 Feb; 35(2):142-51. 1293816
    View PubMed
  489. Xia HH, Kalantar JS, Wyatt JM, Adams S, Cheung K, Eslick GD, Talley NJ. High sensitivity and specificity of a laboratory-based serological test, pylori DTect ELISA, for detection of Helicobacter pylori infection. Diagn Microbiol Infect Dis. 2000 Feb; 36(2):69-74. 1293805
    View PubMed
  490. Reilly WT, Talley NJ, Pemberton JH, Zinsmeister AR. Validation of a questionnaire to assess fecal incontinence and associated risk factors: Fecal Incontinence Questionnaire. Dis Colon Rectum. 2000 Feb; 43(2):146-53; discussion 153-4. 129562
    View PubMed
  491. Koloski NA, Talley NJ, Boyce PM. The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol. 2000 Jan; 95(1):67-71. 1293806
    View PubMed
  492. Xia HH, Kalantar JS, Talley NJ, Wyatt JM, Adams S, Chueng K, Mitchell HM. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia? Am J Gastroenterol. 2000 Jan; 95(1):114-21. 1293804
    View PubMed
  493. Talley NJ. Diagnosis and management of non-ulcer dyspepsia. Primary Care Reports 6(1) 2000 Jan. 1346906
  494. Locke GR 3rd, Zinsmeister AR, Talley NJ, Fett SL, Melton LJ III. Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol. 2000 Jan; 95(1):157-65. 127186
    View PubMed
  495. Pantoflickova D, Blum AL, Talley NJ, Koelz HR. Will eradication of Helicobacter pylori improve symptoms of non-ulcer dyspepsia? Meta-analysis included unreliable studies. Br Med J. 2000; 320:1209. 1346626
    View PubMed
  496. Boyce PM, Koloski NA, Talley NJ. Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice? Am J Gastroenterol. 2000; 95:3176-83. 1293812
    View PubMed
  497. Boyce P, Gilchrist J, Talley NJ, Rose D. Cognitive-behavioural therapy as a treatment for irritable bowel syndrome; a pilot study. Australian and New Zealand Journal of Psychiatry. 2000; 34:300-9. 1293807
    View PubMed
  498. Eslick GD, Talley NJ. Non-cardiac chest pain: squeezing the life out of the Australian healthcare system? Med J Aust. 2000; 173:233-4. 1294365
    View PubMed
  499. Thitiphuree S, Talley NJ. Esomeprazole, a new proton pump inhibitor: pharmacological characteristics and clinical efficacy. Int J Clin Pract. 2000; 54:537-41. 1294359
    View PubMed
  500. Talley NJ. Empirical eradication therapy was better than endoscopy-based management for Helicobacter pylori infection and dyspepsia. ACP Journal Club. 2000; 132:46. 1294354
  501. Westbrook JI, McIntosh JH, Talley NJ. The impact of dyspepsia definition on prevalence estimates: considerations for future researchers. Scand J Gastroenterol. 2000; 35:227-33. 1294355
    View PubMed
  502. Talley NJ. Irritable bowel syndrome: practical management. Aust Fam Physician. 2000; 29:893-8. 1294356
    View PubMed
  503. Hammer J, Talley NJ. Nonulcer dyspepsia. Curr Opin Gastroenterol. 1999 Nov; 15(6):492. 1294344
    View PubMed
  504. Kalantar JS, Talley NJ. The effects of lottery incentive and length of questionnaire on health survey response rates: a randomized study. J Clin Epidemiol. 1999 Nov; 52(11):1117-22. 1293785
    View PubMed
  505. Xia HH, Gallagher C, Hyde D, Talley NJ, Keane CT, O'Morain CA. Comparison between McCoy cell line and HeLa cell line for detecting Helicobacter pylori cytotoxicity: clinical and pathological relevance. Ital J Gastroenterol Hepatol. 1999 Nov; 31(8):663-8. 1293802
    View PubMed
  506. van Zanten SJOV, Talley NJ, Bytzer P, Klein KB, Whorwell PJ, Zinsmeister AR. Design of treatment trials for functional gastrointestinal disorders. Gut. 1999 Sep; 45(Suppl 2):69-77. 1318688
  507. Talley NJ, Verlinden M, Jones M. Validity of a new quality of life scale for functional dyspepsia: a United States multicenter trial of the Nepean Dyspepsia Index. Am J Gastroenterol. 1999 Sep; 94(9):2390-7. 1293797
    View PubMed
  508. Eslick GD, Lim LL, Byles JE, Xia HH, Talley NJ. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol. 1999 Sep; 94(9):2373-9. 1293799
    View PubMed
  509. Howell S, Talley NJ. Does fear of serious disease predict consulting behaviour amongst patients with dyspepsia in general practice? Eur J Gastroenterol Hepatol. 1999 Aug; 11(8):881-6. 1293793
    View PubMed
  510. Oliveria SA, Christos PJ, Talley NJ, Dannenberg AJ. Heartburn risk factors, knowledge, and prevention strategies: a population-based survey of individuals with heartburn. Arch Intern Med. 1999 Jul 26; 159(14):1592-8. 1293800
    View PubMed
  511. Talley NJ. Gastro-esophageal reflux disease in adults. How to treat. Australian Doctor. 1999 Jul 2. 1346901
  512. Roberts RO, Jacobsen SJ, Reilly WT, Pemberton JH, Lieber MM, Talley NJ. Prevalence of combined fecal and urinary incontinence: a community-based study. J Am Geriatr Soc. 1999 Jul; 47(7):837-41. 1009571
    View PubMed
  513. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med. 1999 Jun; 106(6):642-9. 117095
    View PubMed
  514. Meineche-Schmidt V, Talley NJ, Pap A, Kordecki H, Schmid V, Ohlsson L, Wahlqvist P, Wiklund I, Bolling-Sternevald E. Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment: a multicentre 3-month follow-up study. Scand J Gastroenterol. 1999 Jun; 34(6):566-74. 1293777
    View PubMed
  515. Talley NJ, Janssens J, Lauritsen K, Racz I, Bolling-Sternevald E. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. Br Med J. 1999 Mar 27; 318(7187):833-7. 1293781
  516. Talley NJ, Haque M, Wyeth JW, Stace NH, Tytgat GN, Stanghellini V, Holtmann G, Verlinden M, Jones M. Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther. 1999 Feb; 13(2):225-35. 1293773
    View PubMed
  517. Talley NJ. Irritable bowel syndrome: definition, diagnosis and epidemiology. Baillieres Clinical Gastroenterology International Practice and Research. 1999; 13:371-84. 1294345
  518. Xia HH, Talley NJ. Helicobacter pylori eradication in patients with non-ulcer dyspepsia. Drugs. 1999; 58:785-92. 1294348
    View PubMed
  519. Xia HH, Fan X-G, Talley NJ. Clarithromycin resistance in Helicobacter pylori and its clinical relevance. World Journal of Gastroenterology. 1999; 5:263-6. 1294350
    View PubMed
  520. Talley NJ, Axon A, Bytzer P, Holtmann G, Lam SK, Veldhuyzen van Zanten S. Management of uninvestigated and functional dyspepsia: a working party report for the World Congresses of Gastroenterology 1998. Aliment Pharmacol Ther. 1999; 13:1135-48. 1294351
    View PubMed
  521. Talley NJ. How should Helicobacter pylori positive dyspeptic patients be managed? Gut. 1999; 45(Suppl 1):I28-31. 1294352
    View PubMed
  522. Nandurkar S, Talley NJ. Barrett's esophagus: the long and the short of it. Am J Gastroenterol. 1999; 94:1719. 1294335
    View PubMed
  523. Hammer J, Talley NJ. Diagnostic criteria for the irritable bowel syndrome. Am J Med. 1999; 107(Suppl 5A):5S-11S. 1294337
    View PubMed
  524. Talley NJ. Management of dyspepsia and functional dyspepsia: an international perspective. Canadian Journal of Gastroenterology. 1999; 13:685-7. 1294339
    View PubMed
  525. Haag S, Nandurkar S, Talley NJ. Regression of Barrett's esophagus: the role of acid suppression, surgery, and ablative methods. Gastrointestinal Endoscopy. 1999; 50:229-40. 1294340
    View PubMed
  526. Tytgat G, Hungin APS, Malfertheiner P, Talley NJ, Hongo M, McColl K, Soule JC, Agreus L, Bianchi-Porro G, Freston J, Hunt R. Decision making in dyspepsia: controversies in primary and secondary care. Eur J Gastroenterol Hepatol. 1999; 11:223-30. 1294341
    View PubMed
  527. Talley NJ, Stanghellini V, Heading R, Koch KL, Malagelada JR, Tytgat GNJ. Functional gastroduodenal disorders: a working team report for the Rome II consensus on funtional gastrointestinal disorders. Gut. 1999; 45(Suppl 2):II37-42. 1294342
    View PubMed
  528. Talley NJ, Wingate DL. Irritable bowel syndrome and the role of 5-HT. Aliment Pharmacol Ther. 1999; 13(Suppl 2):1-82. 1294343
  529. Talley NJ. Helicobacter pylori and dyspepsia. Yale Journal of Biology and Medicine. 1999; 72:145-51. 1294328
    View PubMed
  530. Dent J, Brun J, Fendrick AM, Fennerty MB, Janssens J, Kahrilas PJ, Lauritsen K, Reynolds JC, Shaw M, Talley NJ. An evidence-based appraisal of reflux disease management: the Genval workshop report. Gut. 1999; 44(Suppl 2):S1-S16. 1294333
    View PubMed
  531. Bolin TD, Korman MG, Stanton R, Talley NJ, Newstead GL, Donnelly N, Hall W, Ho MT, Lapsley H. Positive cost effectiveness of early diagnosis of colorectal cancer. Colorectal Disease. 1999; 1:113-22. 1293784
  532. Lam CM, Kennedy ML, Lubowski DZ, Talley NJ. Prevalence and risk factors for faecal incontinence: a population based study. Colorectal Disease. 1999; 1:197-203. 1293791
  533. Talley NJ, Vakil N, Ballard ED, Fennerty MB. Absence of benefit of eradicating Helicobacter pylori in patients with non-ulcer dyspepsia. N Engl J Med. 1999; 341:1106-11. 1293808
    View PubMed
  534. Kalantar J, Eslick G, Talley NJ. Chronic gastritis and non-ulcer dyspepsia. Curr Top Microbiol Immunol. 1999; 241:31-45. 1346569
    View PubMed
  535. Mackender D, Talley NJ. Cutaneous signs of systemic disease. Current Therapeutics Part. 1999 Jul 1. 1346902
  536. Mackender D, Talley NJ. Cutaneous signs of systemic disease. Current Therapeutics Part. 1999 Jul 2. 1346903
  537. Mackender D, Talley NJ. Cutaneous signs of systemic disease. Current Therapeutics Part. 1999 Jul 3. 1346904
  538. Yeomans N, Talley NJ, Lee A, Katelaris P. Helicobacter pylori: Guidelines for health care providers. Australian Gastroenterology Institute. 1999. 1346905
  539. Blum AL, Talley NJ, O'Morain C, Veldhuyzen van Zanten SV, Labenz J, Stolte M, Louw JA, Stubberod A, Theodors A, Sundin M, Bolling-Sternevald E, Junghard O. Lack of effect of treating Helicobacter pylori infection in patients with non-ulcer dyspepsia. N Engl J Med. 1998 Dec 24; 339(26):1875-81. 1293774
    View PubMed
  540. Bensoussan A, Talley NJ, Hing M, Menzies R, Guo A, Ngu M. Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA. 1998 Nov 11; 280(18):1585-9. 1293772
    View PubMed
  541. Kato M, Kephart GM, Talley NJ, Wagner JM, Sarr MG, Bonno M, McGovern TW, Gleich GJ. Eosinophil infiltration and degranulation in normal human tissue. Anat Rec. 1998 Nov; 252(3):418-25. 1019990
    View PubMed
  542. Shaw M, Talley NJ, Adlis S, Beebe T, Tomshine P, Healey M. Development of a digestive health status instrument: tests of scaling assumptions, structure and reliability in a primary care population. Aliment Pharmacol Ther. 1998 Nov; 12(11):1067-78. 1293768
    View PubMed
  543. Talley NJ, Meineche-Schmidt V, Pare P, Duckworth M, Raisanen P, Pap A, Kordecki H, Schmid V. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther. 1998 Nov; 12(11):1055-65. 1293769
    View PubMed
  544. Talley NJ, Jones M. Self-reported rectal bleeding in a United States community: prevalence, risk factors, and health care seeking. Am J Gastroenterol. 1998 Nov; 93(11):2179-83. 1293770
    View PubMed
  545. Xia HH, Kalantar J, Talley NJ. Metronidazole- and clarithromycin-resistant Helicobacter pylori in dyspeptic patients in Western Sydney as determined by testing multiple isolates from different gastric sites. J Gastroenterol Hepatol. 1998 Oct; 13(10):1044-9. 1293757
    View PubMed
  546. Nandurkar S, Martin CJ, Talley NJ, Wyatt JM. Curable cancer in a short segment Barrett's esophagus. Dis Esophagus. 1998 Oct; 11(4):284-7. 1293788
    View PubMed
  547. Komoto K, Haruma K, Kamada T, Tanaka S, Yoshihara M, Sumii K, Kajiyama G, Talley NJ. Helicobacter pylori infection and gastric neoplasia: correlations with histological gastritis and tumor histology. Am J Gastroenterol. 1998 Aug; 93(8):1271-6. 1293771
    View PubMed
  548. Morris-Yates A, Talley NJ, Boyce PM, Nandurkar S, Andrews G. Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol. 1998 Aug; 93(8):1311-7. 1293766
    View PubMed
  549. Holtmann G, Talley NJ, Mitchell H, Hazell S. Antibody response to specific H. pylori antigens in functional dyspepsia, duodenal ulcer, and health. Am J Gastroenterol. 1998 Aug; 93(8):1222-7. 1293767
    View PubMed
  550. Nandurkar S, Talley NJ, Xia H, Mitchell H, Hazel S, Jones M. Dyspepsia in the community is linked to smoking and aspirin use but not Helicobacter pylori. Arch Intern Med. 1998 Jul 13; 158(13):1427-33. 1293758
    View PubMed
  551. Talley NJ, Lambert JR, Howell S, Xia HH, Lin SK, Agreus L. An evaluation of whole blood testing for Helicobacter pylori in general practice. Aliment Pharmacol Ther. 1998 Jul; 12(7):641-5. 1293765
    View PubMed
  552. Wiklund I, Glise H, Jerndal P, Carlsson J, Talley NJ. Does endoscopy have a positive impact on quality of life in dyspepsia? Gastrointest Endosc. 1998 Jun; 47(6):449-54. 1293759
    View PubMed
  553. Talley NJ, Chang FY, Wyatt JM, Adams S, Lau A, Borody T, Chen TS, Daskolopolos G, Cheung K, Talley NA, Full-Young C, Tseng-Shing C. Nizatidine in combination with amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection. Aliment Pharmacol Ther. 1998 Jun; 12(6):527-32. 1293756
    View PubMed
  554. Talley NJ, Boyce P, Jones M. Dyspepsia and health care seeking in a community: how important are psychological factors? Dig Dis Sci. 1998 May; 43(5):1016-22. 1293755
    View PubMed
  555. Talley NJ, Boyce P, Jones M. Identification of distrinct upper and lower gastrointestinal symptom groupings in an urban population. Gut. 1998 May; 42(5):690-5. 1293763
    View PubMed
  556. Holtmann G, Goebell H, Jockenhoevel F, Talley NJ. Altered vagal and intestinal mechanosensory function in chronic unexplained dyspepsia. Gut. 1998 Apr; 42(4):501-6. 1293764
    View PubMed
  557. Roberts RO, Jacobsen SJ, Rhodes T, Reilly WT, Girman CJ, Talley NJ, Lieber MM. Urinary incontinence in a community-based cohort: prevalence and healthcare-seeking. J Am Geriatr Soc. 1998 Apr; 46(4):467-72. 104497
    View PubMed
  558. Roberts RO, Jacobsen SJ, Jacobson DJ, Reilly WT, Talley NJ, Lieber MM. Natural history of prostatism: high American Urological Association Symptom scores among community-dwelling men and women with urinary incontinence. Urology. 1998 Feb; 51(2):213-9. 103459
    View PubMed
  559. Talley NJ, Boyce PM, Jones M. Is the association between irritable bowel syndrome and abuse explained by neuroticism? A population-based study. Gut. 1998 Jan; 42(1):47-53. 1293753
    View PubMed
  560. Evans JM, Fleming KC, Talley NJ, Schleck CD, Zinsmeister AR, Melton LJ III. Relation of colonic transit to functional bowel disease in older people: a population-based study. J Am Geriatr Soc. 1998 Jan; 46(1):83-7. 102704
    View PubMed
  561. Talley NJ, Eslick GD. Commentary on "Eradication of Helicobacter pylori before NSAID treatment prevented ulcers.". ACP Journal Club. 1998; 128:44. 1294334
  562. Talley NJ. Commentary on review: Misoprostol was most cost-effective if risk for NSAID-related GI events was high. Arthritis Rheum. 1998; 129:25. 1294330
  563. Nandurkar S, Talley NJ. Surveillance in Barrett's esophagus: a need for reassessment? J Gastroenterol Hepatol. 1998; 13:1069-105. 1294332
    View PubMed
  564. Talley NJ, Hau-Xiang Xia H. Helicobacter pylori infection and non-ulcer dyspepsia. British Medical Bulletin. 1998; 54:63-9. 1294324
    View PubMed
  565. Xia HH, Talley NJ. Helicobacter pylori infection, reflux esophagitis, and atrophic gastritis: an unexplored triangle. Am J Gastroenterol. 1998; 93:394-400. 1294325
    View PubMed
  566. Veldhuyzen van Zanten S, Talley NJ. Should antibiotic treatment of Helicobacter positive patients within non-ulcer dyspepsia now be recommended? Eur J Gastroenterol Hepatol. 1998; 10:367-70. 1294326
    View PubMed
  567. Hu WHC, Talley NJ. Functional (non-ulcer) dyspepsia: unexplained but not unmanageable. Med J Aust. 1998; 168:507-12. 1294327
    View PubMed
  568. Talley NJ. Healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions, and relief of dyspeptic symptoms: a commentary on the new data. Am J Med. 1998; 104:S62-6. 1294312
    View PubMed
  569. Talley NJ. Scope of the problem of functional digestive disorders. European Journal of Surgery. 1998; 164(Suppl 582):135-41. 1294315
  570. Talley NJ. Irritable bowel syndrome: disease definition and symptom description. Eur J Surg. 1998; 164(Suppl 583):24-8. 1294319
  571. Talley NJ, Silverstein M, Agreus L, Nyrén O, Sonnenberg A, Holtmann G. AGA technical review-evaluation of dyspepsia. Gastroenterology. 1998; 114:582-95. 1294320
    View PubMed
  572. Lam SK, Talley NJ. Report of the 1997 Asia Pacific Consensus guidelines on the management of H. pylori. J Gastroenterol Hepatol. 1998; 13:1-12. 1294321
    View PubMed
  573. Hammer J, Talley NJ. Non-ulcer dyspepsia: evaluation (including the role of Helicobacter pylori, the role of dysmotility, and management). Curr Opin Gastroenterol. 1998; 14:447-51. 1294338
  574. Niec AM, Frankum B, Talley NJ. Are adverse food reactions linked to irritable bowel syndrome? Am J Gastroenterol. 1998; 93:2184-90. 1294336
    View PubMed
  575. Junghard O, Lauritsen K, Talley NJ, Wiklund IK. Validation of seven graded diary cards for severity of dyspeptic symptoms in patients with non ulcer dyspepsia. Eur J Surg Suppl. 1998; 583:106-11. 1293760
    View PubMed
  576. Wiklund IK, Junghard O, Grace E, Talley NJ, Kamm M, Veldhuyzen van Zanten S, Pare P, Chiba N, Leddin DS, Bigard MA, Colin R, Schoenfeld P. Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl. 1998; (583):41-9. 1346475
  577. Phung N, Kalantar J, Talley NJ. Management of dyspepsia in general practice. Mod Med. 1998; 41:10-18. 1346519
  578. Talley NJ, O'Connor S. Sistema nervioso: exploracion de los nervios craneales (III). Review Salud Rural. 1998; 5:111-30. 1346520
  579. Talley NJ, Kalantar JS. Unexplained weight loss. Curr Ther. 1998; 37-43. 1346521
  580. Holtmann G, Stanghellini V, Talley NJ. Nomenclature of dyspepsia, dyspepsia subgroups and functional dyspepsia: clarifying the concepts. Baillieres Clin Gastroenterol. 1998; 12:417-33. 1346522
    View PubMed
  581. Weltmann M, Talley NJ. The patient with recurrent non-identifiable GI bleeding. Current Therapeutics. 1998. 1346900
  582. Kalantar SJ, Marks R, Lambert JR, Badov D, Talley NJ. Dyspepsia due to eosinophilic gastroenteritis. Dig Dis Sci. 1997 Nov; 42(11):2327-32. 1293752
    View PubMed
  583. Talley NJ, Boyce PM, Jones M. Predictors of health care seeking for irritable bowel syndrome: a population-based study. Gut. 1997 Sep; 41(3):394-8. 1293748
    View PubMed
  584. Talley NA, Chen F, King D, Jones M, Talley NJ. Short chain fatty acids in the treatment of radiation proctitis: a randomized, placebo-controlled crossover trial. Dis Colon Rectum. 1997 Sep; 40(9):1046-50. 1293749
    View PubMed
  585. Nandurkar S, Talley NJ, Martin CJ, Ng THK, Adams S. Short segment Barrett's oesophagus: prevalence, diagnosis, and associations. Gut. 1997 Jun; 40(6):710-5. 1293750
    View PubMed
  586. Holtmann G, Goebell H, Talley NJ. Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis? Am J Gastroenterol. 1997 Jun; 92(6):954-9. 1293747
    View PubMed
  587. Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997 May; 112(5):1448-56. 102347
    View PubMed
  588. Friedrich WN, Talley NJ, Panser L, Fett S, Zinsmeister AR. Concordance of reports of childhood abuse by adults. Child Maltreat. 1997 May; 2(2):164-71. 100127
  589. Frankum B, Talley NJ. The tired listless patient. Curr Ther. 1997 Mar; 41-5. 1346460
  590. Talley NJ, Xia HH. Gastric cancer. An infectious disease? New Zealand Patient Management. 1997; 26:9-11. 1346461
  591. Agreus L, Talley NJ. Dyspepsia: current understanding and management. Annual Review Medicine. 1997; 49:475-93. 1294323
  592. Agreus L, Talley N. Dyspepsia management in general practice. Br Med J. 1997; 315:1284-8. 1294313
  593. McManis PG, Talley NJ. Nausea and vomiting associated with selective serotonin reuptake inhibitors: incidence, mechanisms, and management. CNS Drugs. 1997; 8:394-401. 1294306
  594. Xia HH, Talley NJ, Keane CT, O'Morain CA. Recurrence of Helicobacter pylori infection after successful eradication: nature, possible causes, and potential preventive strategies. Dig Dis Sci. 1997; 42:1821-34. 1294308
    View PubMed
  595. Xia HH, Talley NJ. Natural acquisition and spontaneous elimination of Helicobacter pylori infection: clinical implications. Am J Gastroenterol. 1997; 92:1780-7. 1294309
    View PubMed
  596. Talley NJ, Hunt RH. What role does Helicobacter pylori play in non-ulcer dyspepsia? Arguments for and against H. pylori being associated with dyspeptic symptoms Gastroenterology. 1997; 113(6 Suppl S):S67-77. 1294310
  597. Talley NJ. Dyspepsia and heartburn: a clinical challenge. Aliment Pharmacol Ther. 1997; 11(Suppl 2):1-8. 1294311
  598. Holtmann G, Talley NJ, Goebell H. Association between Helicobacter pylori, duodenal mechanosensory thresholds, and small intestinal motility in chronic unexplained dyspepsia. Dig Dis Sci. 1996 Jul; 41(7):1285-91. 1293661
    View PubMed
  599. Loy C, Irwig L, Katelaris PH, Talley NJ. Do commercial serological kits for Helicobacter pylori infection differ in accuracy?: a meta-analysis. Am J Gastroenterol. 1996 Jun; 91(6):1138-44. 1293660
    View PubMed
  600. Veldhuyzen van Zanten SJ, Cleary C, Talley NJ, Peterson TC, Nyren O, Bradley LA, Verlinden M, Tytgat GN. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for the design of future trials. Am J Gastroenterol. 1996 Apr; 91(4):660-73. 1293658
    View PubMed
  601. Holtmann G, Goebell H, Talley NJ. Impaired small intestinal peristaltic reflexes and sensory thresholds are independent functional disturbances in patients with chronic unexplained dyspepsia. Am J Gastroenterol. 1996 Mar; 91(3):485-91. 1293657
    View PubMed
  602. Talley NJ, Hu WHC. Commentary on "Misoprostol reduced serious NSAID-induced gastrointestinal complications in rheumatoid arthritis.". Ann Intern Med. 1996 Mar-Apr; 124:38. 1294298
  603. Toma TP, Zighelboim J, Phillips SF, Talley NJ. Methods for studying intestinal sensitivity and compliance: in vitro studies of balloons and a barostat. Neurogastroenterol Motil. 1996 Mar; 8(1):19-28. 95483
    View PubMed
  604. Talley NJ, Owen BK, Boyce P, Paterson K. Psychological treatment for irritable bowel syndrome: a critique of controlled treatment trials. Am J Gastroenterol. 1996 Feb; 91(2):277-83. 1293659
    View PubMed
  605. Talley NJ, Fleming KC, Evans JM, O'Keefe EA, Weaver AL, Zinsmeister AR, Melton LJ. Constipation in an elderly community: a study of prevalence and potential risk factors. Am J Gastroenterol. 1996 Jan; 91(1):19-25. 95294
    View PubMed
  606. Silverstein MD, Petterson T, Talley NJ. Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology. 1996 Jan; 110(1):72-83. 96251
    View PubMed
  607. Talley NJ. Modern management of dyspepsia. Aust Fam Physician. 1996; 25:47-52. 1294299
    View PubMed
  608. Hu WHC, Talley NJ. Visceral perception in functional gastrointestinal disorders: disease marker or epiphenomenon? Dig Dis. 1996; 4:276-88. 1294300
  609. Talley NJ. Quality of life in functional dyspepsia. Scand J Gastroenterol. 1996; 31(Suppl 221):21-2. 1294301
  610. Talley NJ. Helicobacter pylori and non-ulcer dyspepsia. Scand J Gastroenterol. 1996; 31(Suppl 220):19-22. 1294303
  611. Xia HH, Talley NJ. Prospects for improved therapy for Helicobacter pylori. (Leading Article). Expert Opin Investig Drugs. 1996; 5:959-76. 1294304
  612. Talley NJ. H. pylori and functional dyspepsia. Excepta Medica. 1996; 5-6. 1346402
  613. Talley NJ. Helicobacter pylori: a role in functional dyspepsia? Motility Clinical Perspective in Gastroenterology. 1996; 34:11-12. 1346403
  614. Talley NJ. The irritable bowel syndrome: the guts of the problem. Resident & Staff Physician. 1996; 42:11-16. 1346406
  615. Talley NJ. Management of peptic ulcer disease. No role for long-term H2RAs. Gastrointestinal Medicine in General Practice. 1996; 8:22-5. 1346407
  616. Talley NJ, Camilleri M. Epidemiological features of functional dyspepsia and irritable bowel syndrome. Clinican. 1996; 14:7-13. 1346408
  617. Talley NJ. Is there a role for H2 -receptor blockers in the treatment of H. pylori gastritis? The Management of Acid Peptic Disorders: An Asian Perspective. 1996; 12:25-9. 1346409
  618. Talley NJ. Irritable bowel syndrome. Australian Doctor. 1996. 1346899
  619. Locke GR III, Talley NJ, Carpenter HA, Harmsen WS, Zinsmeister AR, Melton J. Changes in the site- and histology-specific incidence of gastric cancer during a 50-year period. Gastroenterology. 1995 Dec; 109(6):1750-6. 91192
    View PubMed
  620. Talley NJ, Hu WHC, Holtmann G. Symptoms, investigation and treatment of gastroparesis. Mod Med Aust. 1995 Dec; 27-33. 1346362
  621. Talley NJ, Boyce P, Owen BK. Psychological distress and seasonal symptom changes in irritable bowel syndrome. Am J Gastroenterol. 1995 Dec; 90(12):2115-9. 1293628
    View PubMed
  622. Drossman DA, Talley NJ, Leserman J, Olden KW, Barreiro MA. Sexual and physical abuse and gastrointestinal illness. Review and recommendations. Ann Intern Med. 1995 Nov 15; 123(10):782-94. 1024276
    View PubMed
  623. Talley NJ, Boyce PM, Owen BK, Newman P, Paterson KJ. Initial validation of a bowel symptom questionnaire and measurement of chronic gastrointestinal symptoms in Australians. Aust N Z J Med. 1995 Aug; 25(4):302-8. 1293627
    View PubMed
  624. Talley NJ, Zinsmeister AR, Melton LJ. Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol. 1995 Jul 1; 142(1):76-83. 92937
    View PubMed
  625. O'Keefe EA, Talley NJ, Zinsmeister AR, Jacobsen SJ. Bowel disorders impair functional status and quality of life in the elderly: a population-based study. J Gerontol A Biol Sci Med Sci. 1995 Jul; 50(4):M184-9. 1992990
    View PubMed
  626. Talley NJ, Evans JM, Fleming KC, Harmsen WS, Zinsmeister AR, Melton LJ 3rd. Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly. Dig Dis Sci. 1995 Jun; 40(6):1345-50. 93053
    View PubMed
  627. Talley NJ, Hu WHC. Commentary on "Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy.". Ann Intern Med. 1995 May-Jun; 122:81. 1294296
  628. Zighelboim J, Talley NJ, Phillips SF, Harmsen WS, Zinsmeister AR. Visceral perception in irritable bowel syndrome. Rectal and gastric responses to distension and serotonin type 3 antagonism. Dig Dis Sci. 1995 Apr; 40(4):819-27. 92349
    View PubMed
  629. Talley NJ, Fett SL, Zinsmeister AR. Self-reported abuse and gastrointestinal disease in outpatients: association with irritable bowel-type symptoms. Am J Gastroenterol. 1995 Mar; 90(3):366-71. 92521
    View PubMed
  630. Talley NJ, Weaver AL, Zinsmeister AR. Impact on functional dyspepsia on quality of life. Dig Dis Sci. 1995 Mar; 40:584-589. 92245
    View PubMed
  631. Carpenter HA, Talley NJ. Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis. Gastroenterology. 1995 Mar; 108(3):917-24. 1023311
    View PubMed
  632. Talley NJ. Dyspepsia in the elderly. Mod Med Aust. 1995 Feb; 72-6. 1346360
  633. Owens DM, Nelson DK, Talley NJ. Irritable bowel syndrome: long term prognosis and the physician-patient interaction. Ann Intern Med. 1995 Jan 15; 122(2):107-12. 1293626
    View PubMed
  634. Zighelboim J, MacCarty RL, Talley NJ. Abnormalities in the shape of the duodenal loop on X-ray. Associated with idiopathic antral hypomotility? Dig Dis Sci. 1995 Jan; 40(1):128-33. 1023814
    View PubMed
  635. Bolin T, Hunt R, Korman M, Lambert J, Lee A, Talley NJ. Helicobacter pylori and gastric neoplasia: evolving concepts. Med J Aust. 1995; 163:253-25. 1294297
    View PubMed
  636. Talley NJ. Functional dyspepsia: should treatment be targeted on disturbed physiology? Aliment Pharmacol Ther. 1995; 9:107-15. 1294294
    View PubMed
  637. Holtmann G, Guerra G, Huber J, Goebell H, Talley NJ. Perception of gastric distention: influence of the mode of distention on perception thresholds and gastric compliance. Dig Dis Sci. 1995; 40:2673-7. 1293655
    View PubMed
  638. Lambert J, Lee A, Talley NJ, Yeomans N. Helicobacter pylori: Guidelines for health care providers. Australian Gastroenterology Institute. 1995. 1346898
  639. Talley NJ. Management of dyspepsia. Gastrointestinal Diseases Today. 1995; 4:11-17. 1346361
  640. Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III. Gastrointestinal tract symptoms and self-reported abuse: a population-based study. Gastroenterology. 1994 Oct; 107(4):1040-9. 90207
    View PubMed
  641. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ III. Self-reported diarrhea: what does it mean? Am J Gastroenterol. 1994 Aug; 89(8):1160-4. 88300
    View PubMed
  642. Zighelboim J, Talley NJ, Phillips SF. Response of gastric fundus to rectal distension in healthy persons. Dig Dis Sci. 1994 Jul; 39(7):1441-5. 88335
    View PubMed
  643. Grotz RL, Pemberton JH, Talley NJ, Rath DM, Zinsmeister AR. Discriminant value of psychological distress, symptom profiles, and segmental colonic dysfunction in outpatients with severe idiopathic constipation. Gut. 1994 Jun; 35(6):798-802. 88396
    View PubMed
  644. Talley NJ, Valdovinos M, Petterson TM, Carpenter HA, Melton LJ III. Epidemiology of celiac sprue: a community-based study. Am J Gastroenterol. 1994 Jun; 89(6):843-6. 88372
    View PubMed
  645. Locke GR, Talley NJ, Weaver AL, Zinsmeister AR. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc. 1994 Jun; 69(6):539-47. 87646
    View PubMed
  646. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ 3rd. Smoking, alcohol, and analgesics in dyspepsia and among dyspepsia subgroups: lack of an association in a community. Gut. 1994 May; 35(5):619-24. 88239
    View PubMed
  647. Holtmann G, Talley NJ. Functional dyspepsia. Current treatment recommendations. Curr Ther. 1994 May; 55-63. 1346318
  648. Talley NJ. A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology. 1994 May; 106(5):1174-83. 1293590
    View PubMed
  649. Holtmann G, Goebell H, Holtmann M, Talley NJ. Dyspepsia in healthy blood donors: pattern of symptoms and association with Helicobacter pylori. Dig Dis Sci. 1994 May; 39(5):1090-8. 1293600
    View PubMed
  650. Talley NJ, Weaver AL, Zinsmeister AR. Smoking, alcohol, and nonsteroidal anti-inflammatory drugs in outpatients with functional dyspepsia and among dyspepsia subgroups. Am J Gastroenterol. 1994 Apr; 89(4):524-8. 88370
    View PubMed
  651. Talley NJ. Epidemiology of Helicobacter pylori infection. NIH Consens Statement. 1994 Feb 7-9; 12:1-15. 1346319
  652. Holtmann G, Goebell H, Talley NJ. Dyspepsia in consulters and non-consulters: prevalence, health-care seeking behaviour and risk factors. European Journal of Gastroenterology and Hepatology. 1994; 6:917-24. 1293604
  653. Talley NJ. A relationship between Helicobacter pylori and non-ulcer dyspepsia: is there enough data to know? Eur J Gastroenterol Hepatol. 1994; 6:567-70. 1294288
  654. Talley NJ. Commentary on "Prompt endoscopy was more cost-effective than H2-blockers in dyspepsia.". Ann Intern Med. 1994; 121(Suppl 2). 1294289
  655. Talley NJ. Gastroduodenal motility. Curr Opin Gastroenterol. 1994; 10:618-22. 1294290
  656. Talley NJ. Diagnosis of Helicobacter pylori infection. Infections in Medicine. 1994; (Special Supplement):18-26. 1346316
  657. Talley NJ. Food for thought: the real story behind stomach ulcers. Chem Ind. 1994; 7:259-62. 1346317
  658. Kim CH, Cameron AJ, Hsu JJ, Talley NJ, Trastek VF, Pairolero PC, O'Connor MK, Colwell LJ, Zinsmeister AR. Achalasia: prospective evaluation of relationship between lower esophageal sphincter pressure, esophageal transit, and esophageal diameter and symptoms in response to pneumatic dilation. Mayo Clin Proc. 1993 Nov; 68(11):1067-73. 84531
    View PubMed
  659. Talley NJ, Weaver AL, Tesmer DL, Zinsmeister AR. Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology. 1993 Nov; 105:1378-1386. 84634
    View PubMed
  660. Hammer J, Phillips SF, Talley NJ, Camilleri M. Effect of a 5HT3-antagonist (ondansetron) on rectal sensitivity and compliance in health and the irritable bowel syndrome. Alimentary Pharmacology & Therapeutics. 1993 Oct; 7(5):543-51. 84660
    View PubMed
  661. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ 3rd. Functional constipation and outlet delay: a population-based study. Gastroenterology. 1993 Sep; 105(3):781-90. 84213
    View PubMed
  662. Zighelboim J, Carpenter HA, Talley NJ. A patient with diarrhea, arthralgias, and fever. Gastroenterology. 1993 Sep; 105(3):923-30. 1030038
    View PubMed
  663. Holtmann G, Talley NJ. Functional dyspepsia: current treatment recommendations. Drugs. 1993 Jun; 45(6):918-30. 1294281
    View PubMed
  664. Wolfsen HC, Carpenter HA, Talley NJ. Menetrier's disease: a form of hypertrophic gastropathy or gastritis? Gastroenterology. 1993 May; 104(5):1310-9. 1029688
    View PubMed
  665. Locke GR, Talley NJ. Management of non-ulcer dyspepsia. J Gastroenterol Hepatol. 1993 May-Jun; 8(3):279-86. 1911380
    View PubMed
  666. Talley NJ. Non-ulcer dyspepisa: current approaches to diagnosis and management. Am Fam Physician 1 1993 May; 47(6):1407-16. 1294280
  667. Zighelboim J, Talley NJ. Viewpoints in digestive diseases: what are functional bowel disorders? Gastroenterology. 1993 Apr; 104(4):1196-201. 1294282
    View PubMed
  668. Talley NJ. The role of Helicobacter pylori in non-ulcer dyspepsia. Gastroenterol Clin North Am. 1993 Mar; 22:153-67. 1030410
    View PubMed
  669. Talley NJ, Kramlinger KG, Burton MC, Colwell LJ, Zinsmeister AR. Psychiatric disorders and childhood abuse in the irritable bowel syndrome. Eur J Gastroenterol Hepatol. 1993; 5:647-54. 86406
  670. Talley NJ. The effects of NSAIDs on the gut. Contemp Intern Med. 1993; 5:14-28. 1346278
  671. Talley NJ. Non-steroidal anti-inflammatory drug-induced gatroduodenopathy. Dear Colleague. 1993. 1346896
  672. Talley NJ, Nyren O, Drossman DA, Heaton KW, Veldhuyzen van Zanten SJO, Koch MM, Ransohoff DF. The irritable bowel syndrome: toward optimal design of controlled treatment trials. Gastroenterology International. 1993; 6:189-211. 1294283
  673. Talley NJ. Commentations on "Cholecystectomy and the risk for colorectal cancer.". Ann Intern Med. 1993; 120(Suppl 1). 1294286
  674. Thomas DW, Talley NJ, Mahnovski V, Haight M, Sinatra FR. Rectal mucosal major basic protein in infants with dietary protein-induced colitis. Annals of Allergy. 1993; 71:66-9. 1293588
    View PubMed
  675. Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E, Richter JE, Koch GG. U.S. householder survey of functional gastrointestinal disorders: prevalence, sociodemography, and health impact. Dig Dis Sci. 1993; 38:1569-80. 1293589
    View PubMed
  676. Miralles GD, O'Fallon JR, Talley NJ. Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome. N Engl J Med. 1992 Dec 31; 327(27):1919-23. 81270
    View PubMed
  677. Talley NJ, Kost L, Haddad A, Zinsmeister AR. Comparison of commercial serological tests for detection of Helicobacter pylori antibodies. J Clin Microbiol. 1992 Dec; 30(12):3146-50. 81027
    View PubMed
  678. Talley NJ. Symptom patterns in functional dyspepsia. Eur J Gastroenterol Hepatol. 1992 Aug; 4:597-601. 1040699
  679. Vassallo MJ, Camilleri M, Phillips SF, Steadman CJ, Talley NJ, Hanson RB, Haddad AC. Colonic tone and motility in patients with irritable bowel syndrome. Mayo Clin Proc. 1992 Aug; 67(8):725-31. 80355
    View PubMed
  680. Steadman CJ, Talley NJ, Phillips SF, Zinsmeister AR. Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study. Mayo Clin Proc. 1992 Aug; 67(8):732-8. 80356
    View PubMed
  681. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ 3rd. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol. 1992 Jul 15; 136(2):165-77. 80690
    View PubMed
  682. O'Keefe EA, Talley NJ, Tangalos EG, Zinsmeister AR. A bowel symptom questionnaire for the elderly. J Gerontol. 1992 Jul; 47(4):M116-21. 80249
    View PubMed
  683. Talley NJ, Kephart GM, McGovern TW, Carpenter HA, Gleich GJ. Deposition of eosinophil granule major basic protein in eosinophilic gastroenteritis and celiac disease. Gastroenterology. 1992 Jul; 103(1):137-45. 1040716
    View PubMed
  684. Loeb DS, Talley NJ, Ahlquist DA, Carpenter HA, Zinsmeister AR. Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori. Gastroenterology. 1992 Jun; 102(6):1899-905. 79947
    View PubMed
  685. Talley NJ, Ormand JE, Frie CA, Zinsmeister AR. Stability of pH gradients in vivo across the stomach in Helicobacter pylori gastritis, dyspepsia, and health. Am J Gastroenterol. 1992 May; 87(5):590-4. 79842
    View PubMed
  686. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ 3rd. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology. 1992 Apr; 102(4 Pt 1):1259-68. 79635
    View PubMed
  687. Loeb DS, Ahlquist DA, Talley NJ. Management of gastroduodenopathy associated with use of nonsteroidal anti-inflammatory drugs. Mayo Clin Proc. 1992 Apr; 67(4):354-64. 79594
    View PubMed
  688. Steadman CJ, Phillips SF, Camilleri M, Talley NJ, Haddad A, Hanson R. Control of muscle tone in the human colon. Gut. 1992 Apr; 33(4):541-6. 79862
    View PubMed
  689. Talley NJ, O'Keefe EA, Zinsmeister AR, Melton LJ III. Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology. 1992 Mar; 102:895-901. 79534
    View PubMed
  690. Talley NJ. 5-Hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications. Aliment Pharmacol Ther. 1992; 6:273-89. 1294266
    View PubMed
  691. Talley NJ. Dyspepsia and functional dyspepsia. Clin Perspect Gastroenterol. 1992; 20:4-8. 1346234
  692. Talley NJ. Helicobacter pylori infection. Decision Making in GI Disease. 1992; 5:1-8. 1346235
  693. Talley NJ, Zinsmeister AR, Weaver A, DiMagno EP, Carpenter HA, Perez-Perez GI, Blaser MJ. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst. 1991 Dec 4; 83(23):1734-9. 78051
    View PubMed
  694. Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ 3rd. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology. 1991 Oct; 101(4):927-34. 77169
    View PubMed
  695. Talley NJ, Newell DG, Ormand JE, Carpenter HA, Wilson WR, Zinsmeister AR, Perez-Perez GI, Blaser MJ. Serodiagnosis of Helicobacter pylori: comparison of enzyme-linked immunosorbent assays. J Clin Microbiol. 1991 Aug; 29(8):1635-9. 78050
    View PubMed
  696. O'Keefe E, Talley NJ. The irritable bowel syndrome in the elderly. Gastroenterol Clin North Am. 1991 Jun; 20:369-90. 1036867
  697. O'Keefe E, Talley NJ. Irritable bowel syndrome in the elderly. Clin Geriatr Med. 1991 May; 7(2):265-86. 1037749
    View PubMed
  698. McGovern TW, Talley NJ, Kephart GM, Carpenter HA, Gleich GJ. Eosinophil infiltration and degranulation in Helicobacter pylori-associated chronic gastritis. Dig Dis Sci. 1991 Apr; 36(4):435-40. 1038047
    View PubMed
  699. Ormand JE, Talley NJ, Shorter RG, Conley CR, Carpenter HA, Fich A, Wilson WR, Phillips SF. Prevalence of Helicobacter pylori in specific forms of gastritis: further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. Dig Dis Sci. 1991 Feb; 36:142-145. 75950
    View PubMed
  700. Talley NJ, Phillips SF, Bruce BK, Zinsmeister AR, Wiltgen C, Melton LJ. Multisystem complaints in patients with the irritable bowel syndrome and functional dyspepsia. Eur J Gastroenterol Hepatol. 1991 Jan; 3:71-77. 76132
  701. Fich A, Talley NJ, Shorter RG, Phillips SF. Zollinger-Ellison syndrome. Relation to Helicobacter pylori-associated chronic gastritis and gastric acid secretion. Dig Dis Sci. 1991 Jan; 36(1):10-4. 75754
    View PubMed
  702. Myers MB, Miralles GD, Taylor CA, Gastineau DA, Pisani RJ, Talley NJ. POEMS syndrome with idiopathic flushing mimicking cardinoid syndrome. Am J Med. 1991; 90:646-648. 78545
    View PubMed
  703. Smith RC, Talley NJ, Dent OF, Jones M, Waller SL. Exocrine pancreatic function and chronic unexplained dyspepsia. A case control study. International Journal of Pancreatology. 1991; 8:253-62. 1293570
    View PubMed
  704. Talley NJ, Colin-Jones D, Koch KL, Koch M, Nyren O, Stanghellini V. Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenterology International. 1991; 4:145-60. 1294251
  705. Tygat GNJ, Heading RC, Knill-Jones RP, Richter JE, Malagelada JR, Nyren O, Talley NJ. Towards understanding dyspepsia: an update and consensus from an international working party. Scand J Gastroenterol. 1991; 26(Suppl 182):1-74. 1294257
  706. Talley NJ. Drug treatment of functional dyspepsia. Scand J Gastroenterol. 1991; 26(Suppl 182):47-60. 1294260
  707. Talley NJ. Spectrum of chronic dyspepsia in the prescence of the irritable bowel syndrome. Scand J Gastroenterol. 1991; 26(Suppl 182):7-10. 1294261
  708. Talley NJ. Non-ulcer dyspepsia: myths and realities. Aliment Pharmacol Ther. 1991; 5 (Suppl 1):145-62. 1343840
    View PubMed
  709. Drossman DA, Thompson WG, Talley NJ, Funch-Jensen P, Janssens J, Whitehead WE. Identification of sub-groups of functional gastrointestinal disorders. Gastroenterology International. 1990 Dec; 3:159-172. 1035318
  710. Talley NJ, Phillips SF, Wiltgen CM, Zinsmeister AR, Melton LJ 3rd. Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc. 1990 Nov; 65(11):1456-79. 73837
    View PubMed
  711. Talley NJ, Phillips SF, Bruce B, Twomey CK, Zinsmeister AR, Melton LJ 3rd. Relation among personality and symptoms in nonulcer dyspepsia and the irritable bowel syndrome. Gastroenterology. 1990 Aug; 99(2):327-33. 73079
    View PubMed
  712. Ormand JE, Talley NJ, Carpenter HA, Shorter RG, Conley CR, Wilson WR, DiMagno EP, Zinsmeister AR, Phillips SF. [14C]urea breath test for diagnosis of Helicobacter pylori. Dig Dis Sci. 1990 Jul; 35(7):879-84. 73078
    View PubMed
  713. MacCarty RL, Talley NJ. Barium studies in diffuse eosinophilic gastroenteritis. Gastrointest Radiol. 1990 Summer; 15(3):183-7. 1035570
    View PubMed
  714. Talley NJ, Phillips SF, Haddad A, Miller LJ, Twomey C, Zinsmeister AR, MacCarty RL, Ciociola A. GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man. Dig Dis Sci. 1990 Apr; 35(4):477-80. 72425
    View PubMed
  715. Ormand JE, Talley NJ. Helicobacter pylori: controversies and an approach to management. Mayo Clin Proc. 1990 Mar; 65(3):414-26. 1034267
    View PubMed
  716. Fich A, Talley NJ, Shorter RG, Phillips SF. Does Helicobacter pylori colonize the gastric mucosa of Meckel's diverticulum? Mayo Clin Proc. 1990 Feb; 65(2):187-91. 72122
    View PubMed
  717. Talley NJ, Phillips SF, Melton LJ, Mulvihill C, Wiltgen C, Zinsmeister AR. Diagnostic value of the Manning criteria in irritable bowel syndrome. Gut. 1990 Jan; 31(1):77-81. 1313606
    View PubMed
  718. Talley NJ, Shorter RG, Phillips SF, Zinsmeister AR. Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut. 1990 Jan; 31(1):54-8. 72265
    View PubMed
  719. Pym B, Sandstad J, Seville P, Byth K, Middleton WRJ, Talley NJ, Piper DW. Cost-effectiveness of cimetidine maintenance therapy in chronic gastric and duodenal ulcer. Gastroenterology. 1990; 99:27-35. 1293568
    View PubMed
  720. Talley NJ. A practical approach to dyspepsia. Contemp Intern Med. 1990; 25-33. 1346184
  721. Talley NJ. Helicobacter pylori and chronic gastroduodenal disease. Infectious Diseases Newsletter. 1990; 9:65-7. 1346185
  722. Talley NJ, Chute CG, Larson DE, Epstein R, Lydick EG, Melton LJ 3rd. Risk for colorectal adenocarcinoma in pernicious anemia. A population-based cohort study. Ann Intern Med. 1989 Nov 1; 111(9):738-42. 70167
    View PubMed
  723. Talley NJ, Phillips SF, Melton J 3rd, Wiltgen C, Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med. 1989 Oct 15; 111(8):671-4. 70042
    View PubMed
  724. Talley NJ, Camilleri M, Orkin BA, Kramlinger KG. Effect of cyclical unipolar depression on upper gastrointestinal motility and sleep. Gastroenterology. 1989 Sep; 97(3):775-7. 71421
    View PubMed
  725. Talley NJ. Chronic (nonerosive) gastritis: pathogenesis and management. Dig Dis. 1989; 7(2):61-75. 1045309
    View PubMed
  726. Talley NJ, Phillips SF, Haddad A, Miller LJ, Twomey C, Zinsmeister AR, Ciociola A. Effect of a selective 5HT3 antagonist (GR-38032F) on small intestinal transit and release of gastrointestinal peptides. Dig Dis Sci. 1989; 34:1511-1515. 71208
    View PubMed
  727. Talley NJ, Shuter B, McCrudden G, Jones M, Hoschl R, Piper DW. Lack of association between gastric emptying of solids and symptoms in non-ulcer dyspepsia. J Clin Gastroenterol. 1989; 11:625-30. 1293559
    View PubMed
  728. Ormand JE, Talley NJ. Campylobacter pylori, mucus, and peptic ulceration: a dynamic interaction. J Clin Gastroenterol. 1989; 11:492-5. 1293564
    View PubMed
  729. Talley NJ, Ormand JE. Is antibacterial therapy against Campylobacter pylori useful in the therapy of indigestion and chronic peptic ulceration? Trends in Pharmacological Sciences. 1989; 10:36-40. 1294114
    View PubMed
  730. Talley NJ, Kellow JE, Piper DW. Non-ulcer dyspepsia: a management plan. Curr Ther. 1989; 30:91-103. 1346152
  731. Talley NJ. Upper gastrointestinal distress: guidelines for empirical treatment and investigation. Med Times. 1989; 117:25-8. 1346153
  732. Talley NJ. Campylobacter pylori and chronic peptic ulceration: do bugs cause ulcers? Asociacion de Medicina Interna de Mexico, AC. Clinicas Medicas Mexicanas. Curso Internacional de Medicina Interna. 1989; 3:5-7. 1346154
  733. Talley NJ, Cameron AJ, Shorter RG, Zinsmeister AR, Phillips SF. Campylobacter pylori and Barrett's esophagus. Mayo Clin Proc. 1988 Dec; 63(12):1176-80. 66871
    View PubMed
  734. Talley NJ, Jones M, Piper DW. Psychosocial and childhood factors in essential dyspepsia. A case control study. Scand J Gastroenterol. 1988; 23:341-6. 1293547
    View PubMed
  735. Talley NJ, McNeil D, Piper DW. Environmental factors and chronic unexplained dyspepsia: association with acetaminophen but not other analgesics, alcohol, coffee, tea, or smoking. Digestive Diseases and Sciences. 1988; 33:641-8. 1293548
    View PubMed
  736. Talley NJ, Ellard K, Jones M, Tennant C, Piper DW. Suppression of emotions in essential dyspepsia and chronic duodenal ulcer: a case control study. Scand J Gastroenterol. 1988; 23:337-40. 1293550
    View PubMed
  737. Talley NJ, Eckstein RP, Gattas MR, Stiel D. Acute hepatitis and Brucella melitensis infection: clinicopathological findings. Medical Journal of Australia. 1988; 148:587-90. 1293553
    View PubMed
  738. Talley NJ, Roth A, Woods J, Hench V. Diagnostic value of liver biopsy in alcoholic liver disease. Journal of Clinical Gastroenterology. 1988; 10:647-50. 1293556
    View PubMed
  739. Talley NJ, Phillips SF. Non-ulcer dyspepsia: potential causes and pathophysiology. Ann Intern Med. 1988; 108:865-79. 147357
    View PubMed
  740. Talley NJ, McNeil D, Hayden A, Colreavy C, Piper DW. Prognosis of chronic unexplained dyspepsia. A prospective study of potential predictor variables in patients with endoscopically diagnosed non-ulcer dyspepsia. Gastroenterology. 1987; 92:1060-6. 1293536
    View PubMed
  741. Talley NJ, McNeil D, Piper DW. Discriminant value of dyspeptic symptoms. A study of the clinical presentation of 221 patients with dyspepsia of unknown cause, peptic ulceration, and cholelithiasis. Gut. 1987; 28:40-6. 1293539
    View PubMed
  742. Talley NJ, Piper DW. A prospective study of social factors and major life event stress in patients with dyspepsia of unknown cause. Scand J Gastroenterol. 1987; 22:268-72. 1293542
    View PubMed
  743. Talley NJ. Non-ulcer dyspepsia. Medical Progress. 1987; 31-41. 1346104
  744. Talley NJ. Non-ulcer dyspepsia: what measures help? Curr Ther. 1986; 27:81-97. 1346083
  745. Talley NJ. Are symptoms really useful in diagnosing the cause of dyspepsia? Mod Med Aust. 1986; 29-31. 1346084
  746. Piper DW, Talley NJ, Ellard K. Long-term (maintenance) treatment of chronic peptic ulcer. Mod Med Aust. 1986; 18-21. 1346085
  747. Talley NJ. Dyspepsia and non-ulcer dyspepsia: an historical perspective. Med J Aust. 1986; 145:614-8. 1294112
    View PubMed
  748. Talley NJ, Piper DW. Comparison of the clincial features and illness behaviour of patients presenting with dyspepsia of unknown cause (essential dyspepsia) and organic disease. Australian and New Zealand Journal of Medicine. 1986; 16:352-9. 1293546
    View PubMed
  749. Talley NJ, Piper DW. Major life event stress and dyspepsia of unknown cause: a case control study. Gut. 1986; 27:127-34. 1293521
    View PubMed
  750. Talley NJ, McNeil D, Hayden A, Piper DW. Randomized, double-blind, placebo-controlled crossover trial of cimetidine and pirenzepine in non-ulcer dyspepsia. Gastroenterology. 1986; 91:149-56. 1293525
    View PubMed
  751. Talley NJ, Fung LH, Gilligan IJ, McNeil D, Piper DW. Association of anxiety, neuroticism, and depression with dyspepsia of unknown cause. A case control study. Gastroenterology. 1986; 90:886-92. 1293534
    View PubMed
  752. Fung LH, Gilligan IJ, Talley NJ, Piper DW. Chronic duodenal ulcer, marital status, and personality pattern: a case control study. Journal of Gastroenterology and Hepatology. 1986; 1:251-6. 1293535
  753. Talley NJ, Piper DW. The association between non-ulcer dyspepsia and other gastrointestinal disorders. Scandinavian Journal of Gastroenterology. 1985; 20:896-900. 1293519
    View PubMed
  754. Palmer FJ, Talley NJ. Erdheim-Chester disease with bilateral exophthalmus and liver cell adenoma. Australasian Radiology. 1984; 28:305-10. 1293515
    View PubMed